≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Unspecified human immunodeficiency virus [HIV] disease

EFO Endpoint Browser PheWeb

AB1_HIV_NOS

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — B24
  • Hospital discharge: ICD-9 — 0788A|0788B|0788C
  • Cause of death: ICD-10 — B24
  • Cause of death: ICD-9 — 0788A|0788B|0788C

2 out of 7 registries used, show all original rules.

375

4. Check minimum number of events

None

375

5. Include endpoints

None

375

6. Filter based on genotype QC (FinnGen only)

312

Control definitions (FinnGen only)

Control exclude
AB1_HIV

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF5

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2230 539 1557
Only index persons 1747 492 1255
Unadjusted period prevalence (%)
Whole population 0.04 0.02 0.04
Only index persons 0.04 0.02 0.05
Median age at first event (years)
Whole population 39.14 34.60 41.16
Only index persons 39.53 34.14 41.64

-FinnGen-

Key figures

All Female Male
Number of individuals 312 51 261
Unadjusted period prevalence (%) 0.10 0.02 0.12
Median age at first event (years) 42.21 40.78 42.49

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
375
Matched controls
3750
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
WW200
NOMESCO Finland
Immunization
323.0
307.7
296
43
B23.1
ICD-10 Finland
HIV disease resulting in (persistent) generalized lymphadenopathy
+∞
307.7
324
*
B24
ICD-10 Finland
Unspecified human immunodeficiency virus [HIV] disease
+∞
307.7
370
*
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
37.4
289.5
232
156
Z21
ICD-10 Finland
Asymptomatic human immunodeficiency virus [HIV] infection status
+∞
150.4
134
*
Z25.1
ICD-10 Finland
Need for immunization against influenza
19.5
127.5
111
79
B23.8
ICD-10 Finland
HIV disease resulting in other specified conditions
+∞
124.0
112
*
Z3231
NOMESCO Finland
Registered nurse
9.7
109.9
243
597
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
8.8
71.2
106
160
Z2221
NOMESCO Finland
Medical doctor
5.0
53.2
183
596
B18.2
ICD-10 Finland
Chronic viral hepatitis C
14.2
44.2
42
33
A63.0
ICD-10 Finland
Anogenital (venereal) warts
8.7
40.1
55
73
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
7.4
39.4
63
100
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
5.7
38.6
83
177
B23.0
ICD-10 Finland
Acute HIV infection syndrome
+∞
38.2
36
*
A56.3
ICD-10 Finland
Chlamydial infection of anus and rectum
136.4
35.4
37
*
A51.0
ICD-10 Finland
Primary genital syphilis
356.8
33.4
33
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.6
31.4
239
1236
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
4.4
26.1
77
210
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.9
24.5
87
271
K02.9
ICD-10 Finland
Dental caries, unspecified
10.4
24.4
28
29
A54.6
ICD-10 Finland
Gonococcal infection of anus and rectum
+∞
24.2
23
*
A54.0
ICD-10 Finland
Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess
133.5
23.9
25
*
C10AA07
ATC
rosuvastatin; oral
3.0
23.4
181
899
A51.9
ICD-10 Finland
Early syphilis, unspecified
+∞
23.2
22
*
A53.9
ICD-10 Finland
Syphilis, unspecified
+∞
22.1
21
*
Y25
ICPC
Fear sexually transm disease male
6.2
21.6
39
69
N05CD07
ATC
temazepam; oral
4.6
21.6
57
142
A54.5
ICD-10 Finland
Gonococcal pharyngitis
116.5
20.8
22
*
K05.19
ICD-10 Finland
Gingivitis (chronic) ulcerative
5.8
20.4
39
73
B20.6
ICD-10 Finland
HIV disease resulting in Pneumocystis jirovecii pneumonia
+∞
18.9
18
*
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
5.0
18.0
41
90
B18.1
ICD-10 Finland
Chronic viral hepatitis B without delta-agent
99.8
17.7
19
*
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
5.9
17.3
32
58
J05AB01
ATC
aciclovir; systemic
2.9
17.0
100
418
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
5.9
16.8
31
56
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.6
16.7
42
100
QAJ99
NOMESCO Finland
Other aesthetic operations on skin of head or neck
+∞
15.7
15
*
ULA02
NOMESCO Finland
Kolposcopy
4.5
15.0
39
95
TAB00
NOMESCO Finland
Lumbar puncture
4.6
14.9
37
87
WX110, ,
SPAT
4.0
14.3
44
122
A56.0
ICD-10 Finland
Chlamydial infection of lower genitourinary tract
10.7
14.2
27
27
N05CF01
ATC
zopiclone; oral
2.4
14.2
134
699
Z3226
NOMESCO Finland
Physiotherapist
2.8
13.8
83
347
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.6
13.8
49
150
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.4
13.8
129
669
Z01.2
ICD-10 Finland
Dental examination
2.3
13.7
204
1289
F43.29
ICD-10 Finland
Adaptation disorder UNS
5.5
13.6
27
52
B90
ICPC
HIV-infection/AIDS
+∞
13.6
13
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.6
13.4
97
446
R50.9
ICD-10 Finland
Fever, unspecified
2.7
13.1
85
369
A51.3
ICD-10 Finland
Secondary syphilis of skin and mucous membranes
72.4
12.7
14
*
B20.9
ICD-10 Finland
HIV disease resulting in unspecified infectious or parasitic disease
+∞
12.6
12
*
O98.5
ICD-10 Finland
Other viral diseases complicating pregnancy, childbirth and the puerperium
134.3
12.5
13
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.8
12.0
71
293
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.3
11.7
116
611
EB1AA, ,
SPAT
3.5
11.6
43
135
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
2.3
11.6
110
568
N06AB04
ATC
citalopram; systemic
2.5
11.5
89
419
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
13.3
11.3
19
15
R4110
NOMESCO Finland
Physiotherapy
2.2
11.2
122
666
ZXD35
NOMESCO Finland
Usual procedure
5.1
11.1
24
50
A01AB04
ATC
amphotericin B; local oral
5.8
10.8
20
36
Z71.8
ICD-10 Finland
Other specified counselling
2.1
10.7
144
852
Y71
ICPC
Gonorrhoea male
+∞
10.5
10
*
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
+∞
10.5
10
*
JX1XE
NOMESCO Finland
Other ultrasound examinaton of alimentary organs
+∞
10.5
10
*
K05.31
ICD-10 Finland
Periodontitis pronounced
2.7
10.4
63
263
K02.2
ICD-10 Finland
Caries of cementum
4.1
10.0
28
72
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
26.8
9.9
13
5
TLC00
NOMESCO Finland
Insertion of intrauterine device
4.3
9.9
26
64
UJH02
NOMESCO Finland
Anoscopy
4.4
9.8
25
60
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
8.2
9.8
21
27
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.7
9.7
32
93
WYA30, ,
SPAT
15.6
9.6
15
10
B02.9
ICD-10 Finland
Zoster without complication
3.6
9.6
32
94
B20.0
ICD-10 Finland
HIV disease resulting in mycobacterial infection
+∞
9.4
9
*
P19
ICPC
Drug abuse
11.1
9.4
17
16
J01MA12
ATC
levofloxacin; systemic
2.3
9.3
79
385
UJF30
NOMESCO Finland
Ileoscopy through colon
2.8
9.2
50
197
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.9
8.8
45
171
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.9
8.8
26
70
D06BB10
ATC
imiquimod; topical
3.9
8.8
26
70
D11
ICPC
Diarrhoea
2.5
8.7
59
260
N05BA01
ATC
diazepam; systemic, rectal
2.5
8.7
59
260
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
3.7
8.4
27
77
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
8.4
96
527
A55
ICD-10 Finland
Chlamydial lymphogranuloma (venereum)
+∞
8.4
8
*
B20.1
ICD-10 Finland
HIV disease resulting in other bacterial infections
+∞
8.4
8
*
B20.3
ICD-10 Finland
HIV disease resulting in other viral infections
+∞
8.4
8
*
0788C
ICD-9 Finland
Other diseases due to viruses and Chlamydiae, Other specified diseases due to viruses and Chlamydiae[AIDS, IMMUUNIKATO]
+∞
8.4
8
*
0788B
ICD-9 Finland
Other diseases due to viruses and Chlamydiae, Other specified diseases due to viruses and Chlamydiae[HIV-INFEKTIO,OIREISET TAUDINKUVAT]
+∞
8.4
8
*
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
14.9
8.3
13
9
SAA04
NOMESCO Finland
Special examination of mouth
3.5
8.3
29
88
Z2446
NOMESCO Finland
Social worker
3.1
8.2
35
120
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.9
8.2
41
154
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.4
8.1
63
294
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
10.4
8.1
15
15
ZX114
NOMESCO Finland
Intramuscular
9.7
7.8
15
16
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.5
7.8
27
81
TGC00
NOMESCO Finland
Bronchial lavation
4.7
7.7
18
40
XF400
NOMESCO Finland
ECG with 12 standard connections
2.3
7.7
66
322
C10AA03
ATC
pravastatin; oral
3.6
7.7
26
77
C10AA01
ATC
simvastatin; oral
0.4
7.5
31
758
F15.5
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder
13.7
7.4
12
9
Z3232
NOMESCO Finland
Midwife
3.1
7.4
31
105
N06AA12
ATC
doxepin; systemic
3.6
7.4
24
69
N05BA04
ATC
oxazepam; oral
2.0
7.4
97
558
B20.4
ICD-10 Finland
HIV disease resulting in candidiasis
+∞
7.3
7
*
B20.7
ICD-10 Finland
HIV disease resulting in multiple infections
+∞
7.3
7
*
B23
ICD-10 Finland
Human immunodeficiency virus [HIV] disease resulting in other conditions
+∞
7.3
7
*
A52.9
ICD-10 Finland
Late syphilis, unspecified
+∞
7.3
7
*
B21.3
ICD-10 Finland
HIV disease resulting in other malignant neoplasms of lymphoid, haematopoietic and related tissue
+∞
7.3
7
*
Y70
ICPC
Syphilis male
+∞
7.3
7
*
OAB43, ,
SPAT
0.5
7.2
76
1282
TQW99
NOMESCO Finland
Other minor procedure on skin
3.8
7.1
22
61
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
2.7
7.1
40
160
S02.51
ICD-10 Finland
Fracture of tooth, open
2.4
7.0
48
212
N06AX11
ATC
mirtazapine; oral
1.8
6.9
133
864
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
2.1
6.9
77
416
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
6.8
125
799
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
3.4
6.8
25
78
-1, ,
NOMESCO Finland
1.8
6.7
136
898
SDE04
NOMESCO Finland
Periodontal treatment by dental hygienist, very extensive
2.3
6.6
50
231
J05AB11
ATC
valaciclovir; oral
2.2
6.5
58
287
N07BA03
ATC
varenicline; oral
2.8
6.5
34
131
3044A
ICD-9 Finland
Drug dependence, Amphetamine and other psychostimulant dependence
71.0
6.4
7
*
A52.1
ICD-10 Finland
Symptomatic neurosyphilis
71.0
6.4
7
*
B59
ICD-10 Finland
Pneumocystosis
71.0
6.4
7
*
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
8.4
6.4
13
16
ZXE00
NOMESCO Finland
One hour or less
1.8
6.3
134
892
D07AA02
ATC
hydrocortisone; topical
2.2
6.3
59
298
0788A
ICD-9 Finland
Other diseases due to viruses and Chlamydiae, Other specified diseases due to viruses and Chlamydiae[HIV-PRIMAARI-INFEKTIO JA OIREETON KANTAJAVAIHE]
+∞
6.3
6
*
B16.9
ICD-10 Finland
Acute hepatitis B without delta-agent and without hepatic coma
+∞
6.3
6
*
B22.0
ICD-10 Finland
HIV disease resulting in encephalopathy
+∞
6.3
6
*
A51.5
ICD-10 Finland
Early syphilis, latent
+∞
6.3
6
*
A23
ICPC
Risk factor NOS
2.3
6.2
48
223
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
4.1
6.2
17
43
TLC02
NOMESCO Finland
Simple extraction of IUD
6.5
6.2
15
24
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
5.9
6.2
16
28
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
12.8
6.1
10
8

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Infectious Disease
44 [38004484]
3.8e+00
5.5e+00
—
1.0e+50
—
7.8e+00
7.3e+00
cases:29.95%
controls:0.94%
cases:40.11%
controls:0.27%
—
—
cases:62.30%
controls:0.00%
—
—
cases:84.91%
controls:0.22%
cases:92.31%
controls:0.82%
112
35
262
3697
150
10
224
3722
—
233
0
141
3732
—
315
8
56
3686
324
29
27
3493
Outpatient Visit
OP [9202]
4.2e-01
1.3e+00
2.3e+00
6.4e+00
2.9e+00
3.0e+00
3.0e+00
cases:60.16%
controls:49.76%
cases:59.89%
controls:29.80%
cases:37.43%
controls:5.71%
cases:64.71%
controls:0.29%
cases:55.61%
controls:6.44%
cases:90.03%
controls:31.10%
cases:96.58%
controls:59.43%
225
1857
149
1875
224
1112
150
2620
140
213
234
3519
242
11
132
3721
208
240
166
3488
334
1149
37
2545
339
2093
12
1429
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
1.6e+00
2.3e+00
3.0e+00
1.0e+50
3.4e+00
2.4e+00
2.0e+00
cases:19.79%
controls:4.53%
cases:13.37%
controls:1.58%
cases:5.88%
controls:0.32%
cases:1.87%
controls:0.00%
cases:4.55%
controls:0.16%
cases:16.17%
controls:1.76%
cases:28.21%
controls:5.03%
74
169
300
3563
50
59
324
3673
22
12
352
3720
7
0
367
3732
17
6
357
3722
60
65
311
3629
99
177
252
3345
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
1.4e+00
2.1e+00
2.9e+00
—
3.3e+00
2.7e+00
2.2e+00
cases:8.29%
controls:2.28%
cases:7.49%
controls:1.02%
cases:2.94%
controls:0.16%
—
—
cases:3.48%
controls:0.13%
cases:12.13%
controls:0.92%
cases:29.91%
controls:4.49%
31
85
343
3647
28
38
346
3694
11
6
363
3726
—
13
5
361
3723
45
34
326
3660
105
158
246
3364
Differential panel, method unspecified - Blood
69738-3 [42870588]
1.3e+00
1.9e+00
3.2e+00
1.0e+50
3.3e+00
2.2e+00
2.3e+00
cases:8.29%
controls:2.47%
cases:8.02%
controls:1.23%
cases:6.15%
controls:0.27%
cases:1.87%
controls:0.00%
cases:5.08%
controls:0.19%
cases:10.78%
controls:1.27%
cases:24.79%
controls:3.18%
31
92
343
3640
30
46
344
3686
23
10
351
3722
7
0
367
3732
19
7
355
3721
40
47
331
3647
87
112
264
3410
Basophils/Leukocytes in Blood
30180-4 [3022096]
1.2e+00
1.8e+00
3.1e+00
1.0e+50
3.5e+00
2.4e+00
2.2e+00
cases:10.16%
controls:3.46%
cases:10.16%
controls:1.80%
cases:8.02%
controls:0.38%
cases:3.21%
controls:0.00%
cases:6.42%
controls:0.21%
cases:17.79%
controls:2.00%
cases:36.47%
controls:5.82%
38
129
336
3603
38
67
336
3665
30
14
344
3718
12
0
362
3732
24
8
350
3720
66
74
305
3620
128
205
223
3317
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
1.1e+00
1.8e+00
3.1e+00
1.0e+50
3.5e+00
2.4e+00
2.2e+00
cases:10.16%
controls:3.56%
cases:10.16%
controls:1.80%
cases:8.02%
controls:0.40%
cases:3.21%
controls:0.00%
cases:6.42%
controls:0.21%
cases:17.79%
controls:2.00%
cases:36.18%
controls:5.79%
38
133
336
3599
38
67
336
3665
30
15
344
3717
12
0
362
3732
24
8
350
3720
66
74
305
3620
127
204
224
3318
Monocytes/Leukocytes in Blood
26485-3 [3019069]
1.1e+00
1.8e+00
3.1e+00
1.0e+50
3.5e+00
2.3e+00
2.2e+00
cases:10.16%
controls:3.56%
cases:10.16%
controls:1.82%
cases:8.02%
controls:0.40%
cases:3.21%
controls:0.00%
cases:6.42%
controls:0.21%
cases:17.79%
controls:2.06%
cases:36.18%
controls:5.74%
38
133
336
3599
38
68
336
3664
30
15
344
3717
12
0
362
3732
24
8
350
3720
66
76
305
3618
127
202
224
3320
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
9.8e-01
1.8e+00
3.1e+00
1.0e+50
3.3e+00
2.5e+00
2.3e+00
cases:8.56%
controls:3.38%
cases:8.29%
controls:1.50%
cases:6.68%
controls:0.32%
cases:2.94%
controls:0.00%
cases:6.68%
controls:0.27%
cases:16.71%
controls:1.54%
cases:36.47%
controls:5.48%
32
126
342
3606
31
56
343
3676
25
12
349
3720
11
0
363
3732
25
10
349
3718
62
57
309
3637
128
193
223
3329
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
1.1e+00
1.8e+00
3.0e+00
1.0e+50
3.5e+00
2.4e+00
2.2e+00
cases:10.16%
controls:3.59%
cases:10.16%
controls:1.85%
cases:7.75%
controls:0.40%
cases:2.94%
controls:0.00%
cases:6.42%
controls:0.21%
cases:18.06%
controls:2.00%
cases:35.90%
controls:5.99%
38
134
336
3598
38
69
336
3663
29
15
345
3717
11
0
363
3732
24
8
350
3720
67
74
304
3620
126
211
225
3311
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
1.0e+00
1.8e+00
3.1e+00
1.0e+50
3.5e+00
2.3e+00
2.1e+00
cases:9.63%
controls:3.64%
cases:10.16%
controls:1.85%
cases:8.02%
controls:0.40%
cases:3.21%
controls:0.00%
cases:6.42%
controls:0.21%
cases:17.79%
controls:2.08%
cases:36.47%
controls:6.30%
36
136
338
3596
38
69
336
3663
30
15
344
3717
12
0
362
3732
24
8
350
3720
66
77
305
3617
128
222
223
3300
Basophils [#/volume] in Blood
26444-0 [3006315]
1.0e+00
1.6e+00
2.9e+00
1.0e+50
3.4e+00
2.3e+00
2.1e+00
cases:9.89%
controls:3.78%
cases:10.70%
controls:2.25%
cases:8.56%
controls:0.54%
cases:3.48%
controls:0.00%
cases:7.22%
controls:0.27%
cases:19.14%
controls:2.36%
cases:37.32%
controls:6.62%
37
141
337
3591
40
84
334
3648
32
20
342
3712
13
0
361
3732
27
10
347
3718
71
87
300
3607
131
233
220
3289
Monocytes [#/volume] in Blood
26484-6 [3001604]
1.0e+00
1.6e+00
2.9e+00
1.0e+50
3.4e+00
2.3e+00
2.1e+00
cases:9.89%
controls:3.78%
cases:10.70%
controls:2.28%
cases:8.56%
controls:0.54%
cases:3.48%
controls:0.00%
cases:7.22%
controls:0.27%
cases:19.14%
controls:2.38%
cases:37.32%
controls:6.62%
37
141
337
3591
40
85
334
3647
32
20
342
3712
13
0
361
3732
27
10
347
3718
71
88
300
3606
131
233
220
3289
Eosinophils [#/volume] in Blood
26449-9 [3013115]
1.1e+00
1.6e+00
2.9e+00
1.0e+50
3.4e+00
2.3e+00
2.0e+00
cases:10.43%
controls:3.91%
cases:10.70%
controls:2.28%
cases:8.82%
controls:0.54%
cases:3.48%
controls:0.00%
cases:7.22%
controls:0.27%
cases:19.14%
controls:2.41%
cases:37.32%
controls:7.18%
39
146
335
3586
40
85
334
3647
33
20
341
3712
13
0
361
3732
27
10
347
3718
71
89
300
3605
131
253
220
3269
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
9.7e-01
1.6e+00
2.8e+00
1.0e+50
3.4e+00
2.3e+00
2.1e+00
cases:9.89%
controls:3.99%
cases:10.70%
controls:2.30%
cases:8.56%
controls:0.56%
cases:3.48%
controls:0.00%
cases:7.22%
controls:0.27%
cases:19.14%
controls:2.38%
cases:37.32%
controls:7.07%
37
149
337
3583
40
86
334
3646
32
21
342
3711
13
0
361
3732
27
10
347
3718
71
88
300
3606
131
249
220
3273
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
2.1e+00
3.2e+00
—
—
1.0e+50
4.0e+00
3.7e+00
cases:7.22%
controls:0.96%
cases:7.22%
controls:0.32%
—
—
—
—
cases:4.81%
controls:0.00%
cases:16.71%
controls:0.35%
cases:34.76%
controls:1.25%
27
36
347
3696
27
12
347
3720
—
—
18
0
356
3728
62
13
309
3681
122
44
229
3478
Treatment of a patient needing special arrangements
WYA30 [2001310874]
2.2e+00
2.7e+00
—
—
—
4.0e+00
3.8e+00
cases:4.55%
controls:0.54%
cases:2.41%
controls:0.16%
—
—
—
—
—
—
cases:9.43%
controls:0.19%
cases:25.64%
controls:0.74%
17
20
357
3712
9
6
365
3726
—
—
—
35
7
336
3687
90
26
261
3496
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
7.7e-01
1.2e+00
3.4e+00
1.0e+50
3.2e+00
2.0e+00
1.9e+00
cases:9.63%
controls:4.72%
cases:7.22%
controls:2.33%
cases:5.88%
controls:0.21%
cases:1.87%
controls:0.00%
cases:3.21%
controls:0.13%
cases:14.29%
controls:2.19%
cases:36.18%
controls:8.09%
36
176
338
3556
27
87
347
3645
22
8
352
3724
7
0
367
3732
12
5
362
3723
53
81
318
3613
127
285
224
3237
Short blood count panel - Blood
55429-5 [40758558]
1.6e+00
1.7e+00
2.5e+00
—
2.1e+00
1.9e+00
2.4e+00
cases:8.56%
controls:1.82%
cases:4.55%
controls:0.86%
cases:1.87%
controls:0.16%
—
—
cases:2.14%
controls:0.27%
cases:6.47%
controls:1.06%
cases:24.22%
controls:2.81%
32
68
342
3664
17
32
357
3700
7
6
367
3726
—
8
10
366
3718
24
39
347
3655
85
99
266
3423
Hepatitis B virus core Ab [Presence] in Serum
16933-4 [3021879]
2.2e+00
2.8e+00
1.0e+50
—
1.0e+50
3.5e+00
3.7e+00
cases:6.42%
controls:0.75%
cases:4.28%
controls:0.27%
cases:3.74%
controls:0.00%
—
—
cases:2.41%
controls:0.00%
cases:5.66%
controls:0.19%
cases:23.65%
controls:0.77%
24
28
350
3704
16
10
358
3722
14
0
360
3732
—
9
0
365
3728
21
7
350
3687
83
27
268
3495
Thorax X-ray examination
GD1AA [2001303617]
4.3e-01
1.6e+00
3.0e+00
—
3.7e+00
2.0e+00
1.8e+00
cases:4.81%
controls:3.19%
cases:6.42%
controls:1.34%
cases:3.48%
controls:0.19%
—
—
cases:6.42%
controls:0.16%
cases:7.82%
controls:1.16%
cases:21.37%
controls:4.15%
18
119
356
3613
24
50
350
3682
13
7
361
3725
—
24
6
350
3722
29
43
342
3651
75
146
276
3376
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
9.3e-01
1.5e+00
2.7e+00
—
2.6e+00
2.1e+00
2.0e+00
cases:10.43%
controls:4.39%
cases:10.70%
controls:2.49%
cases:9.09%
controls:0.64%
—
—
cases:7.22%
controls:0.56%
cases:18.60%
controls:2.68%
cases:36.75%
controls:7.47%
39
164
335
3568
40
93
334
3639
34
24
340
3708
—
27
21
347
3707
69
99
302
3595
129
263
222
3259
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
1.9e+00
2.7e+00
—
1.0e+50
1.0e+50
3.4e+00
3.6e+00
cases:7.49%
controls:1.15%
cases:5.35%
controls:0.38%
—
—
cases:1.34%
controls:0.00%
cases:3.21%
controls:0.00%
cases:9.97%
controls:0.35%
cases:29.63%
controls:1.16%
28
43
346
3689
20
14
354
3718
—
5
0
369
3732
12
0
362
3728
37
13
334
3681
104
41
247
3481
Normoblasts [#/volume] in Blood
715-3 [3021589]
1.1e+00
1.4e+00
2.2e+00
—
2.5e+00
1.8e+00
2.1e+00
cases:8.02%
controls:2.92%
cases:8.82%
controls:2.25%
cases:5.35%
controls:0.64%
—
—
cases:4.55%
controls:0.38%
cases:13.48%
controls:2.46%
cases:30.20%
controls:5.11%
30
109
344
3623
33
84
341
3648
20
24
354
3708
—
17
14
357
3714
50
91
321
3603
106
180
245
3342
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6.8e-01
1.1e+00
2.4e+00
1.0e+50
2.9e+00
1.8e+00
1.6e+00
cases:10.96%
controls:5.87%
cases:10.43%
controls:3.64%
cases:8.82%
controls:0.83%
cases:2.41%
controls:0.00%
cases:7.49%
controls:0.46%
cases:17.52%
controls:3.33%
cases:37.04%
controls:10.62%
41
219
333
3513
39
136
335
3596
33
31
341
3701
9
0
365
3732
28
17
346
3711
65
123
306
3571
130
374
221
3148
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
9.0e-01
1.1e+00
2.2e+00
1.0e+50
2.8e+00
1.8e+00
1.6e+00
cases:8.29%
controls:3.54%
cases:5.88%
controls:2.04%
cases:2.14%
controls:0.24%
cases:1.34%
controls:0.00%
cases:3.74%
controls:0.24%
cases:11.59%
controls:2.08%
cases:26.78%
controls:6.98%
31
132
343
3600
22
76
352
3656
8
9
366
3723
5
0
369
3732
14
9
360
3719
43
77
328
3617
94
246
257
3276
Psychiatry
26 [38004469]
1.4e+00
1.5e+00
1.8e+00
—
1.6e+00
2.1e+00
1.6e+00
cases:16.04%
controls:4.39%
cases:9.63%
controls:2.22%
cases:4.55%
controls:0.80%
—
—
cases:4.01%
controls:0.80%
cases:14.56%
controls:2.11%
cases:20.23%
controls:4.91%
60
164
314
3568
36
83
338
3649
17
30
357
3702
—
15
30
359
3698
54
78
317
3616
71
173
280
3349
Venereal disease screening
171128005 [4064905]
2.1e+00
2.7e+00
—
—
—
2.6e+00
2.4e+00
cases:6.95%
controls:0.94%
cases:3.21%
controls:0.21%
—
—
—
—
—
—
cases:2.96%
controls:0.22%
cases:8.55%
controls:0.82%
26
35
348
3697
12
8
362
3724
—
—
—
11
8
360
3686
30
29
321
3493
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
9.8e-01
1.3e+00
2.6e+00
—
2.5e+00
1.2e+00
1.3e+00
cases:6.68%
controls:2.63%
cases:6.15%
controls:1.82%
cases:3.48%
controls:0.27%
—
—
cases:2.14%
controls:0.19%
cases:5.39%
controls:1.65%
cases:14.81%
controls:4.54%
25
98
349
3634
23
68
351
3664
13
10
361
3722
—
8
7
366
3721
20
61
351
3633
52
160
299
3362
Medical doctor
Z2221 [2001311556]
8.6e-01
1.9e+00
—
—
2.6e+00
2.2e+00
2.1e+00
cases:6.68%
controls:2.95%
cases:7.22%
controls:1.10%
—
—
—
—
cases:2.41%
controls:0.19%
cases:11.86%
controls:1.49%
cases:19.37%
controls:2.98%
25
110
349
3622
27
41
347
3691
—
—
9
7
365
3721
44
55
327
3639
68
105
283
3417
Treponema pallidum Ab [Presence] in Serum
22587-0 [3019832]
1.8e+00
2.3e+00
—
—
1.0e+50
2.7e+00
2.5e+00
cases:3.74%
controls:0.67%
cases:3.21%
controls:0.32%
—
—
—
—
cases:1.87%
controls:0.00%
cases:3.77%
controls:0.27%
cases:15.10%
controls:1.48%
14
25
360
3707
12
12
362
3720
—
—
7
0
367
3728
14
10
357
3684
53
52
298
3470
Emergency Room Visit
ER [9203]
7.8e-01
1.3e+00
2.6e+00
—
1.9e+00
1.3e+00
1.2e+00
cases:44.12%
controls:26.50%
cases:25.94%
controls:8.65%
cases:12.03%
controls:1.02%
—
—
cases:7.22%
controls:1.13%
cases:26.42%
controls:8.85%
cases:55.27%
controls:28.02%
165
989
209
2743
97
323
277
3409
45
38
329
3694
—
27
42
347
3686
98
327
273
3367
194
987
157
2535
Internal Medicine
11 [38004456]
6.4e-01
1.1e+00
2.2e+00
—
2.4e+00
1.4e+00
9.5e-01
cases:28.88%
controls:17.58%
cases:17.91%
controls:6.78%
cases:10.70%
controls:1.26%
—
—
cases:10.70%
controls:1.05%
cases:22.10%
controls:6.66%
cases:31.62%
controls:15.19%
108
656
266
3076
67
253
307
3479
40
47
334
3685
—
40
39
334
3689
82
246
289
3448
111
535
240
2987
Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
21613-5 [3006093]
2.0e+00
1.9e+00
—
—
—
2.7e+00
2.2e+00
cases:3.21%
controls:0.46%
cases:1.87%
controls:0.29%
—
—
—
—
—
—
cases:2.43%
controls:0.16%
cases:7.41%
controls:0.91%
12
17
362
3715
7
11
367
3721
—
—
—
9
6
362
3688
26
32
325
3490
Protein [Mass/volume] in Urine
2888-6 [3037121]
3.8e+00
—
—
—
—
—
4.9e+00
cases:6.68%
controls:0.16%
—
—
—
—
—
—
—
—
—
—
cases:31.62%
controls:0.34%
25
6
349
3726
—
—
—
—
—
111
12
240
3510
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
1.4e+00
1.6e+00
2.5e+00
—
—
1.6e+00
1.6e+00
cases:6.15%
controls:1.53%
cases:3.21%
controls:0.70%
cases:1.87%
controls:0.16%
—
—
—
—
cases:3.50%
controls:0.70%
cases:7.98%
controls:1.76%
23
57
351
3675
12
26
362
3706
7
6
367
3726
—
—
13
26
358
3668
28
62
323
3460
Anogenital (venereal) warts
A63.0 [45585929]
2.3e+00
—
—
—
—
2.7e+00
3.4e+00
cases:3.21%
controls:0.32%
—
—
—
—
—
—
—
—
cases:2.70%
controls:0.19%
cases:5.41%
controls:0.20%
12
12
362
3720
—
—
—
—
10
7
361
3687
19
7
332
3515
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
2.1e+00
—
—
—
1.0e+50
2.7e+00
3.5e+00
cases:4.28%
controls:0.56%
—
—
—
—
—
—
cases:1.87%
controls:0.00%
cases:4.04%
controls:0.27%
cases:17.09%
controls:0.62%
16
21
358
3711
—
—
—
7
0
367
3728
15
10
356
3684
60
22
291
3500
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
3.5e-01
6.3e-01
2.8e+00
1.0e+50
3.2e+00
1.2e+00
1.0e+00
cases:7.49%
controls:5.39%
cases:5.08%
controls:2.76%
cases:6.42%
controls:0.43%
cases:1.87%
controls:0.00%
cases:4.81%
controls:0.21%
cases:8.63%
controls:2.65%
cases:26.21%
controls:11.24%
28
201
346
3531
19
103
355
3629
24
16
350
3716
7
0
367
3732
18
8
356
3720
32
98
339
3596
92
396
259
3126
Outpatient Hospital
22 [8756]
9.3e-02
8.4e-01
2.7e+00
—
2.8e+00
1.2e+00
5.8e-01
cases:18.72%
controls:17.34%
cases:10.16%
controls:4.64%
cases:5.08%
controls:0.38%
—
—
cases:6.15%
controls:0.40%
cases:14.56%
controls:4.66%
cases:25.36%
controls:16.04%
70
647
304
3085
38
173
336
3559
19
14
355
3718
—
23
15
351
3713
54
172
317
3522
89
565
262
2957
Inpatient Hospital
21 [8717]
1.9e-01
8.3e-01
2.5e+00
—
2.5e+00
1.3e+00
6.8e-01
cases:27.27%
controls:23.61%
cases:14.44%
controls:6.83%
cases:8.02%
controls:0.72%
—
—
cases:9.89%
controls:0.89%
cases:21.83%
controls:6.79%
cases:33.90%
controls:20.58%
102
881
272
2851
54
255
320
3477
30
27
344
3705
—
37
33
337
3695
81
251
290
3443
119
725
232
2797
Sytologyspecimen from mouth of uterus
XLD00 [2001306651]
2.2e+00
2.3e+00
—
—
—
—
3.2e+00
cases:4.01%
controls:0.46%
cases:2.94%
controls:0.29%
—
—
—
—
—
—
—
—
cases:9.69%
controls:0.45%
15
17
359
3715
11
11
363
3721
—
—
—
—
34
16
317
3506
Dentistry
C5 [903277]
1.0e+00
2.0e+00
—
—
—
2.6e+00
1.5e+00
cases:4.28%
controls:1.55%
cases:4.01%
controls:0.59%
—
—
—
—
—
—
cases:5.93%
controls:0.46%
cases:7.12%
controls:1.62%
16
58
358
3674
15
22
359
3710
—
—
—
22
17
349
3677
25
57
326
3465
Severe depressive episode without psychotic symptoms
F32.2 [45557202]
2.0e+00
—
—
—
—
2.8e+00
2.3e+00
cases:2.41%
controls:0.32%
—
—
—
—
—
—
—
—
cases:2.70%
controls:0.16%
cases:3.99%
controls:0.43%
9
12
365
3720
—
—
—
—
10
6
361
3688
14
15
337
3507
Fasting glucose [Moles/volume] in Serum or Plasma
14771-0 [3018251]
4.0e-01
7.1e-01
2.5e+00
—
1.9e+00
1.1e+00
7.2e-01
cases:11.23%
controls:7.80%
cases:9.89%
controls:5.14%
cases:5.61%
controls:0.51%
—
—
cases:2.14%
controls:0.32%
cases:14.02%
controls:5.09%
cases:32.48%
controls:18.94%
42
291
332
3441
37
192
337
3540
21
19
353
3713
—
8
12
366
3716
52
188
319
3506
114
667
237
2855
Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
24111-7 [3011371]
2.3e+00
2.1e+00
—
—
—
—
2.3e+00
cases:3.21%
controls:0.32%
cases:1.87%
controls:0.24%
—
—
—
—
—
—
—
—
cases:7.12%
controls:0.74%
12
12
362
3720
7
9
367
3723
—
—
—
—
25
26
326
3496
Abdominal ultrasound examination
JN3AE [2001305555]
—
2.0e+00
—
1.0e+50
—
2.6e+00
2.1e+00
—
—
cases:1.60%
controls:0.21%
—
—
cases:1.87%
controls:0.00%
—
—
cases:3.23%
controls:0.24%
cases:6.55%
controls:0.88%
—
6
8
368
3724
—
7
0
367
3732
—
12
9
359
3685
23
31
328
3491
pH of Urine
2756-5 [3015736]
4.4e-01
1.2e+00
2.8e+00
—
—
1.7e+00
8.8e-01
cases:4.01%
controls:2.63%
cases:4.55%
controls:1.37%
cases:2.94%
controls:0.19%
—
—
—
—
cases:6.20%
controls:1.14%
cases:12.82%
controls:5.74%
15
98
359
3634
17
51
357
3681
11
7
363
3725
—
—
23
42
348
3652
45
202
306
3320
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
9.2e-01
2.0e+00
—
—
—
2.5e+00
2.2e+00
cases:1.34%
controls:0.54%
cases:1.60%
controls:0.21%
—
—
—
—
—
—
cases:2.16%
controls:0.19%
cases:3.13%
controls:0.37%
5
20
369
3712
6
8
368
3724
—
—
—
8
7
363
3687
11
13
340
3509
FEV1 percent change
69983-5 [42868472]
9.2e-01
2.0e+00
—
—
—
2.5e+00
2.2e+00
cases:1.34%
controls:0.54%
cases:1.60%
controls:0.21%
—
—
—
—
—
—
cases:2.16%
controls:0.19%
cases:3.13%
controls:0.37%
5
20
369
3712
6
8
368
3724
—
—
—
8
7
363
3687
11
13
340
3509
FVC percent change Respiratory system
69982-7 [42868471]
9.2e-01
2.0e+00
—
—
—
2.5e+00
2.2e+00
cases:1.34%
controls:0.54%
cases:1.60%
controls:0.21%
—
—
—
—
—
—
cases:2.16%
controls:0.19%
cases:3.13%
controls:0.37%
5
20
369
3712
6
8
368
3724
—
—
—
8
7
363
3687
11
13
340
3509
FEV1 --post bronchodilation
20155-8 [3023550]
9.2e-01
2.0e+00
—
—
—
2.5e+00
2.2e+00
cases:1.34%
controls:0.54%
cases:1.60%
controls:0.21%
—
—
—
—
—
—
cases:2.16%
controls:0.19%
cases:3.13%
controls:0.37%
5
20
369
3712
6
8
368
3724
—
—
—
8
7
363
3687
11
13
340
3509
FEV1/FVC --post bronchodilation
69970-2 [42868459]
9.2e-01
2.0e+00
—
—
—
2.5e+00
2.2e+00
cases:1.34%
controls:0.54%
cases:1.60%
controls:0.21%
—
—
—
—
—
—
cases:2.16%
controls:0.19%
cases:3.13%
controls:0.37%
5
20
369
3712
6
8
368
3724
—
—
—
8
7
363
3687
11
13
340
3509
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
7.8e-01
1.7e+00
2.9e+00
—
—
2.0e+00
6.8e-01
cases:2.94%
controls:1.37%
cases:4.28%
controls:0.83%
cases:2.41%
controls:0.13%
—
—
—
—
cases:5.12%
controls:0.76%
cases:5.70%
controls:2.98%
11
51
363
3681
16
31
358
3701
9
5
365
3727
—
—
19
28
352
3666
20
105
331
3417
Leukocytes [#/volume] in Urine
30405-5 [3018095]
7.0e-01
1.1e+00
2.6e+00
—
—
1.5e+00
1.2e+00
cases:4.01%
controls:2.04%
cases:4.01%
controls:1.34%
cases:2.41%
controls:0.19%
—
—
—
—
cases:5.66%
controls:1.38%
cases:11.68%
controls:3.72%
15
76
359
3656
15
50
359
3682
9
7
365
3725
—
—
21
51
350
3643
41
131
310
3391
Cholesterol in HDL [Moles/volume] in Serum or Plasma
14646-4 [3023602]
3.3e-01
6.7e-01
2.0e+00
1.0e+50
1.8e+00
1.1e+00
7.4e-01
cases:11.23%
controls:8.33%
cases:9.63%
controls:5.17%
cases:4.55%
controls:0.62%
cases:1.34%
controls:0.00%
cases:4.01%
controls:0.67%
cases:14.29%
controls:5.31%
cases:36.47%
controls:21.47%
42
311
332
3421
36
193
338
3539
17
23
357
3709
5
0
369
3732
15
25
359
3703
53
196
318
3498
128
756
223
2766
Cholesterol [Moles/volume] in Serum or Plasma
14647-2 [3019900]
2.7e-01
6.4e-01
2.0e+00
1.0e+50
1.8e+00
1.1e+00
7.3e-01
cases:10.96%
controls:8.63%
cases:9.63%
controls:5.33%
cases:4.55%
controls:0.64%
cases:1.34%
controls:0.00%
cases:4.01%
controls:0.67%
cases:14.56%
controls:5.50%
cases:36.47%
controls:21.66%
41
322
333
3410
36
199
338
3533
17
24
357
3708
5
0
369
3732
15
25
359
3703
54
203
317
3491
128
763
223
2759
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
3.0e-01
6.0e-01
1.9e+00
1.0e+50
2.0e+00
1.0e+00
7.1e-01
cases:12.83%
controls:9.83%
cases:13.64%
controls:7.98%
cases:9.36%
controls:1.50%
cases:2.94%
controls:0.00%
cases:8.29%
controls:1.26%
cases:19.95%
controls:8.12%
cases:38.46%
controls:23.57%
48
367
326
3365
51
298
323
3434
35
56
339
3676
11
0
363
3732
31
47
343
3681
74
300
297
3394
135
830
216
2692
valaciclovir; oral
J05AB11 [21603137]
8.9e-01
2.7e+00
—
—
—
2.0e+00
1.4e+00
cases:1.87%
controls:0.78%
cases:4.01%
controls:0.27%
—
—
—
—
—
—
cases:2.70%
controls:0.38%
cases:4.56%
controls:1.11%
7
29
367
3703
15
10
359
3722
—
—
—
10
14
361
3680
16
39
335
3483
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
2.4e-01
5.7e-01
2.2e+00
—
2.3e+00
9.5e-01
7.2e-01
cases:11.50%
controls:9.30%
cases:9.89%
controls:5.84%
cases:9.09%
controls:1.13%
—
—
cases:8.02%
controls:0.86%
cases:14.02%
controls:5.93%
cases:33.62%
controls:19.76%
43
347
331
3385
37
218
337
3514
34
42
340
3690
—
30
32
344
3696
52
219
319
3475
118
696
233
2826
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
2.7e-01
6.2e-01
1.8e+00
—
1.7e+00
9.8e-01
9.4e-01
cases:9.63%
controls:7.50%
cases:11.50%
controls:6.51%
cases:7.75%
controls:1.37%
—
—
cases:6.42%
controls:1.18%
cases:15.63%
controls:6.52%
cases:33.90%
controls:16.72%
36
280
338
3452
43
243
331
3489
29
51
345
3681
—
24
44
350
3684
58
241
313
3453
119
589
232
2933
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
2.8e-01
1.0e+00
2.6e+00
—
—
1.6e+00
8.1e-01
cases:3.74%
controls:2.87%
cases:4.28%
controls:1.61%
cases:2.94%
controls:0.21%
—
—
—
—
cases:7.82%
controls:1.68%
cases:14.81%
controls:7.21%
14
107
360
3625
16
60
358
3672
11
8
363
3724
—
—
29
62
342
3632
52
254
299
3268
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
2.5e-01
9.9e-01
2.6e+00
—
—
1.6e+00
8.0e-01
cases:3.74%
controls:2.95%
cases:4.28%
controls:1.63%
cases:2.94%
controls:0.21%
—
—
—
—
cases:7.82%
controls:1.65%
cases:14.81%
controls:7.24%
14
110
360
3622
16
61
358
3671
11
8
363
3724
—
—
29
61
342
3633
52
255
299
3267
desonide
D07AB08 [21602112]
1.4e+00
2.4e+00
—
—
—
2.2e+00
1.1e+00
cases:3.48%
controls:0.88%
cases:2.67%
controls:0.24%
—
—
—
—
—
—
cases:2.16%
controls:0.24%
cases:2.85%
controls:0.99%
13
33
361
3699
10
9
364
3723
—
—
—
8
9
363
3685
10
35
341
3487
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
2.2e-01
9.9e-01
2.6e+00
—
—
1.6e+00
8.1e-01
cases:3.74%
controls:3.03%
cases:4.28%
controls:1.63%
cases:2.94%
controls:0.21%
—
—
—
—
cases:7.82%
controls:1.73%
cases:14.81%
controls:7.21%
14
113
360
3619
16
61
358
3671
11
8
363
3724
—
—
29
64
342
3630
52
254
299
3268
Triglyceride [Moles/volume] in Serum or Plasma --fasting
47210-0 [3048773]
3.2e-01
6.0e-01
2.1e+00
1.0e+50
1.9e+00
1.1e+00
8.6e-01
cases:10.96%
controls:8.17%
cases:8.29%
controls:4.72%
cases:4.28%
controls:0.56%
cases:1.34%
controls:0.00%
cases:3.21%
controls:0.51%
cases:12.94%
controls:4.60%
cases:36.47%
controls:19.51%
41
305
333
3427
31
176
343
3556
16
21
358
3711
5
0
369
3732
12
19
362
3709
48
170
323
3524
128
687
223
2835
oxazepam; oral
N05BA04 [21604569]
1.3e+00
8.6e-01
1.9e+00
—
1.9e+00
1.1e+00
1.3e+00
cases:7.75%
controls:2.14%
cases:3.48%
controls:1.50%
cases:1.60%
controls:0.24%
—
—
cases:1.87%
controls:0.30%
cases:4.85%
controls:1.65%
cases:11.40%
controls:3.49%
29
80
345
3652
13
56
361
3676
6
9
368
3723
—
7
11
367
3717
18
61
353
3633
40
123
311
3399
Hemoglobin A1c/Hemoglobin.total in Blood
4548-4 [3004410]
3.8e-01
4.9e-01
1.9e+00
—
1.7e+00
9.5e-01
9.2e-01
cases:9.63%
controls:6.81%
cases:8.56%
controls:5.41%
cases:3.74%
controls:0.56%
—
—
cases:2.41%
controls:0.46%
cases:12.94%
controls:5.44%
cases:35.04%
controls:17.72%
36
254
338
3478
32
202
342
3530
14
21
360
3711
—
9
17
365
3711
48
201
323
3493
123
624
228
2898
zopiclone; oral
N05CF01 [21604654]
1.2e+00
1.5e+00
—
—
1.3e+00
1.6e+00
1.2e+00
cases:10.96%
controls:3.48%
cases:7.22%
controls:1.74%
—
—
—
—
cases:2.41%
controls:0.64%
cases:9.97%
controls:2.27%
cases:14.25%
controls:4.74%
41
130
333
3602
27
65
347
3667
—
—
9
24
365
3704
37
84
334
3610
50
167
301
3355
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
2.0e-01
5.0e-01
1.8e+00
—
1.9e+00
8.9e-01
6.5e-01
cases:12.30%
controls:10.29%
cases:13.90%
controls:8.95%
cases:10.16%
controls:1.80%
—
—
cases:8.02%
controls:1.29%
cases:19.95%
controls:9.26%
cases:39.03%
controls:24.99%
46
384
328
3348
52
334
322
3398
38
67
336
3665
—
30
48
344
3680
74
342
297
3352
137
880
214
2642
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
LC2BE [2001306544]
1.1e+00
1.3e+00
—
—
—
2.3e+00
1.8e+00
cases:3.74%
controls:1.31%
cases:2.14%
controls:0.62%
—
—
—
—
—
—
cases:4.58%
controls:0.49%
cases:7.41%
controls:1.25%
14
49
360
3683
8
23
366
3709
—
—
—
17
18
354
3676
26
44
325
3478
Depressive episode, unspecified
F32.9 [45571760]
1.5e+00
1.3e+00
—
—
—
2.1e+00
1.5e+00
cases:2.67%
controls:0.62%
cases:1.34%
controls:0.38%
—
—
—
—
—
—
cases:2.70%
controls:0.32%
cases:6.55%
controls:1.53%
10
23
364
3709
5
14
369
3718
—
—
—
10
12
361
3682
23
54
328
3468
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
4.0e-01
5.7e-01
1.8e+00
—
1.5e+00
8.1e-01
9.6e-01
cases:9.89%
controls:6.86%
cases:9.89%
controls:5.84%
cases:6.68%
controls:1.15%
—
—
cases:4.01%
controls:0.89%
cases:12.94%
controls:6.23%
cases:31.34%
controls:14.82%
37
256
337
3476
37
218
337
3514
25
43
349
3689
—
15
33
359
3695
48
230
323
3464
110
522
241
3000
Cholesterol in LDL [Moles/volume] in Serum or Plasma
22748-8 [3001308]
2.8e-01
4.8e-01
1.7e+00
1.0e+50
1.7e+00
9.0e-01
6.8e-01
cases:11.23%
controls:8.74%
cases:9.89%
controls:6.38%
cases:4.28%
controls:0.78%
cases:1.34%
controls:0.00%
cases:4.01%
controls:0.75%
cases:14.29%
controls:6.33%
cases:36.75%
controls:22.69%
42
326
332
3406
37
238
337
3494
16
29
358
3703
5
0
369
3732
15
28
359
3700
53
234
318
3460
129
799
222
2723
Emergency Medicine
93 [38004510]
-2.1e-01
5.9e-01
2.7e+00
—
2.3e+00
8.0e-01
5.3e-02
cases:3.74%
controls:4.58%
cases:4.28%
controls:2.41%
cases:3.48%
controls:0.24%
—
—
cases:1.60%
controls:0.16%
cases:5.66%
controls:2.63%
cases:10.54%
controls:10.05%
14
171
360
3561
16
90
358
3642
13
9
361
3723
—
6
6
368
3722
21
97
350
3597
37
354
314
3168
Reagin Ab [Titer] in Serum by VDRL
50690-7 [3029634]
—
—
1.0e+50
—
1.0e+50
—
5.0e+00
—
—
—
—
cases:3.74%
controls:0.00%
—
—
cases:4.01%
controls:0.00%
—
—
cases:25.07%
controls:0.23%
—
—
14
0
360
3732
—
15
0
359
3728
—
88
8
263
3514
Platelets [#/volume] in Blood
26515-7 [3007461]
1.3e-01
5.0e-01
1.8e+00
—
1.8e+00
7.8e-01
4.4e-01
cases:13.37%
controls:11.95%
cases:15.78%
controls:10.21%
cases:12.03%
controls:2.14%
—
—
cases:9.89%
controls:1.72%
cases:20.22%
controls:10.40%
cases:39.03%
controls:29.27%
50
446
324
3286
59
381
315
3351
45
80
329
3652
—
37
64
337
3664
75
384
296
3310
137
1031
214
2491
Biopsy of vaginal cervix
LDA20 [2001306656]
1.7e+00
—
—
—
—
—
3.2e+00
cases:2.14%
controls:0.40%
—
—
—
—
—
—
—
—
—
—
cases:3.99%
controls:0.17%
8
15
366
3717
—
—
—
—
—
14
6
337
3516
MCH [Entitic mass]
28539-5 [3035941]
1.3e-01
4.9e-01
1.8e+00
—
1.8e+00
7.7e-01
4.3e-01
cases:13.37%
controls:11.98%
cases:15.78%
controls:10.29%
cases:12.03%
controls:2.14%
—
—
cases:9.89%
controls:1.72%
cases:20.22%
controls:10.50%
cases:39.03%
controls:29.39%
50
447
324
3285
59
384
315
3348
45
80
329
3652
—
37
64
337
3664
75
388
296
3306
137
1035
214
2487
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
1.3e-01
4.9e-01
1.8e+00
—
1.8e+00
7.7e-01
4.3e-01
cases:13.37%
controls:11.98%
cases:15.78%
controls:10.26%
cases:12.03%
controls:2.17%
—
—
cases:9.89%
controls:1.72%
cases:20.22%
controls:10.48%
cases:39.03%
controls:29.47%
50
447
324
3285
59
383
315
3349
45
81
329
3651
—
37
64
337
3664
75
387
296
3307
137
1038
214
2484
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
1.3e-01
4.9e-01
1.8e+00
—
1.8e+00
7.7e-01
4.3e-01
cases:13.37%
controls:11.98%
cases:15.78%
controls:10.29%
cases:12.03%
controls:2.17%
—
—
cases:9.89%
controls:1.72%
cases:20.22%
controls:10.50%
cases:39.03%
controls:29.44%
50
447
324
3285
59
384
315
3348
45
81
329
3651
—
37
64
337
3664
75
388
296
3306
137
1037
214
2485
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
1.3e-01
4.9e-01
1.8e+00
—
1.8e+00
7.7e-01
4.3e-01
cases:13.37%
controls:11.98%
cases:15.78%
controls:10.29%
cases:12.03%
controls:2.17%
—
—
cases:9.89%
controls:1.72%
cases:20.22%
controls:10.50%
cases:39.03%
controls:29.47%
50
447
324
3285
59
384
315
3348
45
81
329
3651
—
37
64
337
3664
75
388
296
3306
137
1038
214
2484
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
1.3e-01
4.9e-01
1.8e+00
—
1.8e+00
7.7e-01
4.2e-01
cases:13.37%
controls:11.98%
cases:15.78%
controls:10.32%
cases:12.03%
controls:2.17%
—
—
cases:9.89%
controls:1.72%
cases:20.22%
controls:10.50%
cases:39.03%
controls:29.59%
50
447
324
3285
59
385
315
3347
45
81
329
3651
—
37
64
337
3664
75
388
296
3306
137
1042
214
2480
Leukocytes [#/volume] in Blood
26464-8 [3010813]
1.3e-01
4.8e-01
1.8e+00
—
1.8e+00
7.7e-01
4.2e-01
cases:13.37%
controls:11.98%
cases:15.78%
controls:10.34%
cases:12.03%
controls:2.17%
—
—
cases:9.89%
controls:1.72%
cases:20.22%
controls:10.53%
cases:39.03%
controls:29.53%
50
447
324
3285
59
386
315
3346
45
81
329
3651
—
37
64
337
3664
75
389
296
3305
137
1040
214
2482
temazepam; oral
N05CD07 [21604642]
1.1e+00
1.1e+00
—
—
1.8e+00
2.0e+00
1.7e+00
cases:4.01%
controls:1.34%
cases:2.67%
controls:0.94%
—
—
—
—
cases:1.60%
controls:0.27%
cases:5.12%
controls:0.70%
cases:8.55%
controls:1.70%
15
50
359
3682
10
35
364
3697
—
—
6
10
368
3718
19
26
352
3668
30
60
321
3462
Gastroenterology
10 [38004455]
8.2e-01
1.0e+00
2.1e+00
—
—
1.6e+00
1.1e+00
cases:4.81%
controls:2.17%
cases:3.21%
controls:1.21%
cases:1.87%
controls:0.24%
—
—
—
—
cases:6.20%
controls:1.30%
cases:9.97%
controls:3.44%
18
81
356
3651
12
45
362
3687
7
9
367
3723
—
—
23
48
348
3646
35
121
316
3401
Physiotherapist
Z3226 [2001311560]
3.9e-01
1.5e+00
—
1.0e+50
—
1.5e+00
1.7e+00
cases:2.41%
controls:1.63%
cases:2.41%
controls:0.54%
—
—
cases:1.34%
controls:0.00%
—
—
cases:2.96%
controls:0.65%
cases:6.84%
controls:1.28%
9
61
365
3671
9
20
365
3712
—
5
0
369
3732
—
11
24
360
3670
24
45
327
3477
Kolposcopy
ULA02 [2001306679]
2.2e+00
—
—
—
—
—
2.5e+00
cases:3.74%
controls:0.43%
—
—
—
—
—
—
—
—
—
—
cases:5.13%
controls:0.43%
14
16
360
3716
—
—
—
—
—
18
15
333
3507
Dermatitis, unspecified
L30.9 [45572271]
4.6e-01
1.7e+00
—
—
—
1.7e+00
1.3e+00
cases:1.60%
controls:1.02%
cases:2.41%
controls:0.43%
—
—
—
—
—
—
cases:2.43%
controls:0.46%
cases:5.13%
controls:1.45%
6
38
368
3694
9
16
365
3716
—
—
—
9
17
362
3677
18
51
333
3471
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
1.5e-01
4.7e-01
2.6e+00
—
1.8e+00
1.3e+00
7.8e-01
cases:5.08%
controls:4.39%
cases:3.21%
controls:2.04%
cases:3.48%
controls:0.27%
—
—
cases:1.60%
controls:0.27%
cases:6.47%
controls:1.79%
cases:14.53%
controls:7.21%
19
164
355
3568
12
76
362
3656
13
10
361
3722
—
6
10
368
3718
24
66
347
3628
51
254
300
3268
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
1.9e-01
5.7e-01
1.8e+00
—
1.7e+00
7.3e-01
4.1e-01
cases:11.23%
controls:9.46%
cases:12.30%
controls:7.37%
cases:8.29%
controls:1.42%
—
—
cases:5.88%
controls:1.18%
cases:14.56%
controls:7.58%
cases:31.05%
controls:22.94%
42
353
332
3379
46
275
328
3457
31
53
343
3679
—
22
44
352
3684
54
280
317
3414
109
808
242
2714
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
3.8e-01
-2.2e-03
2.3e+00
—
—
1.2e+00
1.0e+00
cases:3.48%
controls:2.41%
cases:1.34%
controls:1.34%
cases:2.14%
controls:0.21%
—
—
—
—
cases:3.77%
controls:1.19%
cases:9.12%
controls:3.55%
13
90
361
3642
5
50
369
3682
8
8
366
3724
—
—
14
44
357
3650
32
125
319
3397
FEV1
20150-9 [3024653]
7.8e-01
1.8e+00
—
—
—
2.1e+00
2.3e+00
cases:1.34%
controls:0.62%
cases:1.60%
controls:0.27%
—
—
—
—
—
—
cases:2.16%
controls:0.27%
cases:3.70%
controls:0.40%
5
23
369
3709
6
10
368
3722
—
—
—
8
10
363
3684
13
14
338
3508
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
7.8e-01
1.8e+00
—
—
—
2.1e+00
2.3e+00
cases:1.34%
controls:0.62%
cases:1.60%
controls:0.27%
—
—
—
—
—
—
cases:2.16%
controls:0.27%
cases:3.70%
controls:0.40%
5
23
369
3709
6
10
368
3722
—
—
—
8
10
363
3684
13
14
338
3508
FEV1/FVC
19926-5 [3011505]
7.8e-01
1.8e+00
—
—
—
2.1e+00
2.3e+00
cases:1.34%
controls:0.62%
cases:1.60%
controls:0.27%
—
—
—
—
—
—
cases:2.16%
controls:0.27%
cases:3.70%
controls:0.40%
5
23
369
3709
6
10
368
3722
—
—
—
8
10
363
3684
13
14
338
3508
Oral Surgery
19 [38004464]
7.4e-01
2.5e+00
—
—
—
1.8e+00
6.6e-01
cases:1.34%
controls:0.64%
cases:1.60%
controls:0.13%
—
—
—
—
—
—
cases:2.16%
controls:0.35%
cases:1.42%
controls:0.74%
5
24
369
3708
6
5
368
3727
—
—
—
8
13
363
3681
5
26
346
3496
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
-5.6e-02
2.4e-01
1.7e+00
—
2.0e+00
6.6e-01
2.6e-01
cases:8.56%
controls:9.00%
cases:8.82%
controls:7.07%
cases:6.68%
controls:1.34%
—
—
cases:6.15%
controls:0.91%
cases:13.48%
controls:7.42%
cases:25.93%
controls:21.32%
32
336
342
3396
33
264
341
3468
25
50
349
3682
—
23
34
351
3694
50
274
321
3420
91
751
260
2771
Gynaecological examination (general)(routine)
Z01.4 [45542395]
1.3e+00
—
—
—
—
2.6e+00
1.6e+00
cases:2.41%
controls:0.70%
—
—
—
—
—
—
—
—
cases:2.96%
controls:0.22%
cases:4.27%
controls:0.85%
9
26
365
3706
—
—
—
—
11
8
360
3686
15
30
336
3492
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
2.7e-01
8.4e-01
2.0e+00
—
2.2e+00
6.0e-01
3.1e-01
cases:3.74%
controls:2.89%
cases:3.48%
controls:1.53%
cases:1.60%
controls:0.21%
—
—
cases:2.41%
controls:0.27%
cases:2.16%
controls:1.19%
cases:6.27%
controls:4.66%
14
108
360
3624
13
57
361
3675
6
8
368
3724
—
9
10
365
3718
8
44
363
3650
22
164
329
3358
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
8.8e-04
2.2e-01
1.6e+00
—
1.9e+00
6.5e-01
2.4e-01
cases:9.09%
controls:9.08%
cases:8.82%
controls:7.18%
cases:6.68%
controls:1.37%
—
—
cases:6.15%
controls:0.99%
cases:13.48%
controls:7.55%
cases:25.93%
controls:21.58%
34
339
340
3393
33
268
341
3464
25
51
349
3681
—
23
37
351
3691
50
279
321
3415
91
760
260
2762
ECG with 12 standard connections
XF400 [2001303368]
9.3e-01
2.3e+00
—
—
—
2.7e+00
1.5e+00
cases:2.67%
controls:1.07%
cases:1.34%
controls:0.13%
—
—
—
—
—
—
cases:1.89%
controls:0.14%
cases:2.56%
controls:0.60%
10
40
364
3692
5
5
369
3727
—
—
—
7
5
364
3689
9
21
342
3501
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
1.2e+00
—
—
—
—
1.7e+00
1.2e+00
cases:3.74%
controls:1.13%
—
—
—
—
—
—
—
—
cases:2.43%
controls:0.46%
cases:5.13%
controls:1.59%
14
42
360
3690
—
—
—
—
9
17
362
3677
18
56
333
3466
Abnormal findings in specimens from female genital organs, abnormal cytological findings
R87.6 [45558487]
1.7e+00
1.7e+00
—
—
—
—
2.4e+00
cases:2.14%
controls:0.40%
cases:1.34%
controls:0.24%
—
—
—
—
—
—
—
—
cases:4.56%
controls:0.43%
8
15
366
3717
5
9
369
3723
—
—
—
—
16
15
335
3507
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
3.4e-01
6.3e-01
2.0e+00
—
2.1e+00
4.4e-01
3.2e-01
cases:3.74%
controls:2.71%
cases:2.67%
controls:1.45%
cases:1.60%
controls:0.21%
—
—
cases:1.87%
controls:0.24%
cases:1.89%
controls:1.22%
cases:5.41%
controls:3.98%
14
101
360
3631
10
54
364
3678
6
8
368
3724
—
7
9
367
3719
7
45
364
3649
19
140
332
3382
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
—
—
—
—
—
2.7e+00
1.4e+00
—
—
—
—
—
—
—
—
—
—
cases:2.70%
controls:0.19%
cases:3.70%
controls:0.94%
—
—
—
—
—
10
7
361
3687
13
33
338
3489
Poisoning by systemic antibiotics
T36 [45756588]
1.9e+00
—
—
—
—
—
2.2e+00
cases:2.67%
controls:0.43%
—
—
—
—
—
—
—
—
—
—
cases:2.28%
controls:0.26%
10
16
364
3716
—
—
—
—
—
8
9
343
3513
Ileoscopy through colon
UJF30 [2001305028]
—
—
—
—
—
2.2e+00
1.9e+00
—
—
—
—
—
—
—
—
—
—
cases:1.62%
controls:0.19%
cases:3.13%
controls:0.48%
—
—
—
—
—
6
7
365
3687
11
17
340
3505
Fever, unspecified
R50.9 [45582716]
1.8e+00
—
—
1.0e+50
—
2.2e+00
6.2e-01
cases:4.55%
controls:0.78%
—
—
—
—
cases:1.34%
controls:0.00%
—
—
cases:1.89%
controls:0.22%
cases:1.99%
controls:1.08%
17
29
357
3703
—
—
5
0
369
3732
—
7
8
364
3686
7
38
344
3484
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
8.8e-01
1.6e+00
—
—
—
2.3e+00
7.0e-01
cases:4.28%
controls:1.82%
cases:2.41%
controls:0.48%
—
—
—
—
—
—
cases:4.04%
controls:0.41%
cases:5.70%
controls:2.92%
16
68
358
3664
9
18
365
3714
—
—
—
15
15
356
3679
20
103
331
3419
Supplier / Service Provider
OMOP5117446 [33004]
-1.5e+00
-1.3e+00
—
—
—
2.9e+00
3.9e+00
cases:7.49%
controls:27.49%
cases:2.41%
controls:8.39%
—
—
—
—
—
—
cases:4.85%
controls:0.27%
cases:15.95%
controls:0.40%
28
1026
346
2706
9
313
365
3419
—
—
—
18
10
353
3684
56
14
295
3508
Moderate depressive episode without somatic syndrome
F32.10 [2000501980]
9.7e-01
—
—
—
—
2.3e+00
1.6e+00
cases:1.34%
controls:0.51%
—
—
—
—
—
—
—
—
cases:1.89%
controls:0.19%
cases:3.13%
controls:0.65%
5
19
369
3713
—
—
—
—
7
7
364
3687
11
23
340
3499
Protein [Presence] in Urine by Test strip
20454-5 [3014051]
7.6e-01
1.8e+00
—
—
—
2.0e+00
4.4e-01
cases:2.94%
controls:1.39%
cases:3.74%
controls:0.62%
—
—
—
—
—
—
cases:4.85%
controls:0.70%
cases:5.13%
controls:3.35%
11
52
363
3680
14
23
360
3709
—
—
—
18
26
353
3668
18
118
333
3404
Office Visit
OMOP4822458 [581477]
4.6e-01
1.0e+00
—
—
2.1e+00
1.6e+00
1.2e+00
cases:9.89%
controls:6.51%
cases:4.81%
controls:1.80%
—
—
—
—
cases:1.34%
controls:0.16%
cases:7.01%
controls:1.57%
cases:16.52%
controls:5.54%
37
243
337
3489
18
67
356
3665
—
—
5
6
369
3722
26
58
345
3636
58
195
293
3327
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
2.8e-03
3.1e-01
1.7e+00
1.0e+50
2.0e+00
4.0e-01
-1.4e-03
cases:5.61%
controls:5.60%
cases:4.01%
controls:2.97%
cases:2.67%
controls:0.48%
cases:1.34%
controls:0.00%
cases:2.41%
controls:0.32%
cases:3.77%
controls:2.57%
cases:12.25%
controls:12.27%
21
209
353
3523
15
111
359
3621
10
18
364
3714
5
0
369
3732
9
12
365
3716
14
95
357
3599
43
432
308
3090
Immunization
WW200 [2001310599]
3.7e+00
—
—
1.0e+50
1.0e+50
—
—
cases:5.35%
controls:0.13%
—
—
—
—
cases:1.34%
controls:0.00%
cases:2.41%
controls:0.00%
—
—
—
—
20
5
354
3727
—
—
5
0
369
3732
9
0
365
3728
—
—
olanzapine; oral, parenteral
N05AH03 [21604543]
1.1e+00
1.4e+00
—
—
-1.0e+50
1.8e+00
1.8e+00
cases:2.14%
controls:0.72%
cases:1.87%
controls:0.48%
—
—
—
—
cases:0.00%
controls:0.21%
cases:2.43%
controls:0.41%
cases:3.99%
controls:0.65%
8
27
366
3705
7
18
367
3714
—
—
0
8
374
3720
9
15
362
3679
14
23
337
3499
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
4.5e-01
—
2.5e+00
—
—
1.2e+00
1.2e+00
cases:2.67%
controls:1.71%
—
—
cases:1.60%
controls:0.13%
—
—
—
—
cases:2.96%
controls:0.95%
cases:7.41%
controls:2.47%
10
64
364
3668
—
6
5
368
3727
—
—
11
35
360
3659
26
87
325
3435
Ultrasound examination of upper part of abdomen
JN1AE [2001305517]
1.2e+00
—
—
—
—
—
3.6e+00
cases:1.60%
controls:0.48%
—
—
—
—
—
—
—
—
—
—
cases:8.55%
controls:0.26%
6
18
368
3714
—
—
—
—
—
30
9
321
3513
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
-1.0e+50
—
—
—
—
2.2e+00
1.4e+00
cases:0.00%
controls:0.29%
—
—
—
—
—
—
—
—
cases:2.96%
controls:0.35%
cases:4.27%
controls:1.05%
0
11
374
3721
—
—
—
—
11
13
360
3681
15
37
336
3485
Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]
-1.0e+50
—
—
—
—
2.1e+00
1.5e+00
cases:0.00%
controls:0.21%
—
—
—
—
—
—
—
—
cases:2.70%
controls:0.35%
cases:4.27%
controls:0.97%
0
8
374
3724
—
—
—
—
10
13
361
3681
15
34
336
3488
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
1.3e-01
8.0e-01
3.5e+00
—
—
—
-2.7e-02
cases:2.14%
controls:1.88%
cases:1.60%
controls:0.72%
cases:6.15%
controls:0.19%
—
—
—
—
—
—
cases:2.85%
controls:2.92%
8
70
366
3662
6
27
368
3705
23
7
351
3725
—
—
—
10
103
341
3419
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
-1.0e+50
—
—
—
—
2.1e+00
1.4e+00
cases:0.00%
controls:0.32%
—
—
—
—
—
—
—
—
cases:2.96%
controls:0.38%
cases:4.27%
controls:1.11%
0
12
374
3720
—
—
—
—
11
14
360
3680
15
39
336
3483
Case Management Agency
251B00000X [38004193]
-1.4e-01
7.7e-02
6.9e-01
2.8e+00
4.9e-01
3.0e-01
1.8e-01
cases:31.02%
controls:33.98%
cases:31.55%
controls:29.90%
cases:18.98%
controls:10.53%
cases:10.70%
controls:0.75%
cases:14.97%
controls:9.74%
cases:40.16%
controls:33.19%
cases:64.39%
controls:60.19%
116
1268
258
2464
118
1116
256
2616
71
393
303
3339
40
28
334
3704
56
363
318
3365
149
1226
222
2468
226
2120
125
1402
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
5.7e-01
—
2.3e+00
—
—
1.1e+00
1.1e+00
cases:3.21%
controls:1.85%
—
—
cases:1.60%
controls:0.16%
—
—
—
—
cases:3.23%
controls:1.11%
cases:9.12%
controls:3.12%
12
69
362
3663
—
6
6
368
3726
—
—
12
41
359
3653
32
110
319
3412
Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
21416-3 [3003510]
8.1e-01
1.2e+00
—
—
—
1.8e+00
1.7e+00
cases:2.67%
controls:1.21%
cases:1.87%
controls:0.56%
—
—
—
—
—
—
cases:2.16%
controls:0.38%
cases:9.40%
controls:1.87%
10
45
364
3687
7
21
367
3711
—
—
—
8
14
363
3680
33
66
318
3456
Blasts/Leukocytes in Blood
26446-5 [3025159]
-1.0e+50
—
—
—
—
2.1e+00
1.3e+00
cases:0.00%
controls:0.32%
—
—
—
—
—
—
—
—
cases:2.70%
controls:0.35%
cases:3.70%
controls:1.02%
0
12
374
3720
—
—
—
—
10
13
361
3681
13
36
338
3486
alprazolam; oral
N05BA12 [21604577]
1.3e+00
2.0e+00
2.3e+00
—
—
1.2e+00
1.2e+00
cases:3.74%
controls:1.05%
cases:3.48%
controls:0.48%
cases:1.34%
controls:0.13%
—
—
—
—
cases:1.62%
controls:0.51%
cases:3.42%
controls:1.11%
14
39
360
3693
13
18
361
3714
5
5
369
3727
—
—
6
19
365
3675
12
39
339
3483
Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6357-8 [3024950]
7.6e-01
1.1e+00
2.3e+00
—
—
1.6e+00
1.7e+00
cases:3.21%
controls:1.53%
cases:1.87%
controls:0.62%
cases:1.34%
controls:0.13%
—
—
—
—
cases:2.43%
controls:0.49%
cases:10.54%
controls:2.16%
12
57
362
3675
7
23
367
3709
5
5
369
3727
—
—
9
18
362
3676
37
76
314
3446
mirtazapine; oral
N06AX11 [21604740]
8.3e-01
8.9e-01
—
—
1.1e+00
1.2e+00
1.2e+00
cases:6.95%
controls:3.16%
cases:4.01%
controls:1.69%
—
—
—
—
cases:1.60%
controls:0.56%
cases:6.74%
controls:2.06%
cases:13.96%
controls:4.66%
26
118
348
3614
15
63
359
3669
—
—
6
21
368
3707
25
76
346
3618
49
164
302
3358
CBC panel - Blood by Automated count
58410-2 [40761511]
-2.2e-01
6.9e-02
1.4e+00
—
1.8e+00
3.6e-01
-1.0e-02
cases:8.02%
controls:9.78%
cases:7.49%
controls:7.02%
cases:4.55%
controls:1.13%
—
—
cases:5.61%
controls:1.02%
cases:9.43%
controls:6.77%
cases:22.51%
controls:22.69%
30
365
344
3367
28
262
346
3470
17
42
357
3690
—
21
38
353
3690
35
250
336
3444
79
799
272
2723
Physiotherapy
R4110 [2001310233]
3.6e-01
1.1e+00
—
1.0e+50
1.0e+50
1.6e+00
1.5e+00
cases:2.94%
controls:2.06%
cases:2.14%
controls:0.70%
—
—
cases:1.60%
controls:0.00%
cases:1.60%
controls:0.00%
cases:3.23%
controls:0.65%
cases:8.83%
controls:2.10%
11
77
363
3655
8
26
366
3706
—
6
0
368
3732
6
0
368
3728
12
24
359
3670
31
74
320
3448
Laboratory Visit
OMOP4822461 [32036]
6.3e-03
2.2e-01
1.3e+00
—
1.3e+00
4.7e-01
2.4e-01
cases:14.17%
controls:14.09%
cases:16.84%
controls:14.01%
cases:13.37%
controls:3.97%
—
—
cases:12.30%
controls:3.67%
cases:20.75%
controls:14.08%
cases:41.03%
controls:35.43%
53
526
321
3206
63
523
311
3209
50
148
324
3584
—
46
137
328
3591
77
520
294
3174
144
1248
207
2274
Essential (primary) hypertension
I10 [45591453]
-1.2e-01
5.9e-01
1.6e+00
—
1.9e+00
1.1e+00
3.7e-01
cases:4.81%
controls:5.39%
cases:5.08%
controls:2.89%
cases:1.87%
controls:0.38%
—
—
cases:2.94%
controls:0.43%
cases:9.70%
controls:3.36%
cases:14.25%
controls:10.31%
18
201
356
3531
19
108
355
3624
7
14
367
3718
—
11
16
363
3712
36
124
335
3570
50
363
301
3159
Pneumonia, unspecified
J18.9 [45601123]
-8.0e-02
1.6e+00
—
1.0e+50
—
1.5e+00
1.3e+00
cases:1.34%
controls:1.45%
cases:2.41%
controls:0.48%
—
—
cases:3.21%
controls:0.00%
—
—
cases:1.89%
controls:0.43%
cases:6.55%
controls:1.79%
5
54
369
3678
9
18
365
3714
—
12
0
362
3732
—
7
16
364
3678
23
63
328
3459
Need for immunization against influenza
Z25.1 [45581017]
2.1e+00
—
—
—
—
—
2.8e+00
cases:1.34%
controls:0.16%
—
—
—
—
—
—
—
—
—
—
cases:7.69%
controls:0.48%
5
6
369
3726
—
—
—
—
—
27
17
324
3505
Hemolysis interference index of Serum or Plasma
46424-8 [3052851]
-1.0e+50
—
—
—
—
—
2.8e+00
cases:0.00%
controls:0.29%
—
—
—
—
—
—
—
—
—
—
cases:3.13%
controls:0.20%
0
11
374
3721
—
—
—
—
—
11
7
340
3515
Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
70200-1 [42868674]
—
—
—
—
—
1.6e+00
1.2e+00
—
—
—
—
—
—
—
—
—
—
cases:2.43%
controls:0.51%
cases:4.27%
controls:1.39%
—
—
—
—
—
9
19
362
3675
15
49
336
3473
sertraline; oral
N06AB06 [21604714]
1.2e+00
1.4e+00
—
—
—
1.5e+00
1.2e+00
cases:2.94%
controls:0.91%
cases:2.14%
controls:0.54%
—
—
—
—
—
—
cases:2.70%
controls:0.62%
cases:3.42%
controls:1.02%
11
34
363
3698
8
20
366
3712
—
—
—
10
23
361
3671
12
36
339
3486
General Practice
1 [38004446]
6.7e-01
8.7e-01
1.8e+00
1.0e+50
—
1.2e+00
3.2e-01
cases:11.23%
controls:6.08%
cases:5.61%
controls:2.44%
cases:1.60%
controls:0.27%
cases:1.87%
controls:0.00%
—
—
cases:7.28%
controls:2.36%
cases:12.25%
controls:9.23%
42
227
332
3505
21
91
353
3641
6
10
368
3722
7
0
367
3732
—
27
87
344
3607
43
325
308
3197
Panorama tomography of teeth and jaws or similar X-ray examination
EB1HA [2001301913]
-2.5e-01
5.9e-01
—
—
—
2.0e+00
7.3e-01
cases:2.41%
controls:3.05%
cases:1.87%
controls:1.05%
—
—
—
—
—
—
cases:5.39%
controls:0.79%
cases:9.12%
controls:4.60%
9
114
365
3618
7
39
367
3693
—
—
—
20
29
351
3665
32
162
319
3360
Urinary tract ultrasound examination
KH1AE [2001306329]
—
—
—
—
—
—
2.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.85%
controls:0.20%
—
—
—
—
—
—
10
7
341
3515
combinations of corticosteroids
D07AB30 [21602118]
8.6e-01
9.9e-01
—
—
1.4e+00
8.2e-01
3.0e-02
cases:14.97%
controls:6.94%
cases:7.22%
controls:2.81%
—
—
—
—
cases:1.34%
controls:0.32%
cases:5.93%
controls:2.71%
cases:8.55%
controls:8.32%
56
259
318
3473
27
105
347
3627
—
—
5
12
369
3716
22
100
349
3594
30
293
321
3229
combinations of corticosteroids
D07XB30 [21602188]
8.6e-01
9.9e-01
—
—
1.4e+00
8.2e-01
3.0e-02
cases:14.97%
controls:6.94%
cases:7.22%
controls:2.81%
—
—
—
—
cases:1.34%
controls:0.32%
cases:5.93%
controls:2.71%
cases:8.55%
controls:8.32%
56
259
318
3473
27
105
347
3627
—
—
5
12
369
3716
22
100
349
3594
30
293
321
3229
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5.5e-01
—
—
—
—
1.5e+00
1.2e+00
cases:2.94%
controls:1.71%
—
—
—
—
—
—
—
—
cases:3.50%
controls:0.84%
cases:7.12%
controls:2.24%
11
64
363
3668
—
—
—
—
13
31
358
3663
25
79
326
3443
Scheduled procedure
ZXD10 [2001311387]
1.2e-01
5.8e-01
—
—
—
1.3e+00
1.4e+00
cases:4.01%
controls:3.56%
cases:1.34%
controls:0.75%
—
—
—
—
—
—
cases:3.50%
controls:1.00%
cases:10.83%
controls:2.98%
15
133
359
3599
5
28
369
3704
—
—
—
13
37
358
3657
38
105
313
3417
Pharmacy visit
OMOP4822462 [581458]
-3.8e-01
1.8e-01
4.5e-01
1.6e+00
6.2e-01
3.9e-01
6.5e-01
cases:79.95%
controls:85.37%
cases:72.99%
controls:69.32%
cases:38.24%
controls:28.27%
cases:6.15%
controls:1.34%
cases:41.71%
controls:27.71%
cases:77.90%
controls:70.49%
cases:95.16%
controls:91.14%
299
3186
75
546
273
2587
101
1145
143
1055
231
2677
23
50
351
3682
156
1033
218
2695
289
2604
82
1090
334
3210
17
312
Hepatitis B virus surface Ab [Units/volume] in Serum
16935-9 [3023421]
1.8e+00
—
1.0e+50
—
1.0e+50
—
2.6e+00
cases:1.34%
controls:0.21%
—
—
cases:1.34%
controls:0.00%
—
—
cases:2.41%
controls:0.00%
—
—
cases:3.42%
controls:0.26%
5
8
369
3724
—
5
0
369
3732
—
9
0
365
3728
—
12
9
339
3513
Obstetrics / Gynecology
16 [38004461]
3.5e-01
6.7e-01
—
1.0e+50
1.5e+00
1.5e+00
1.1e+00
cases:10.16%
controls:7.37%
cases:6.15%
controls:3.24%
—
—
cases:3.48%
controls:0.00%
cases:1.34%
controls:0.30%
cases:12.67%
controls:3.11%
cases:16.81%
controls:6.50%
38
275
336
3457
23
121
351
3611
—
13
0
361
3732
5
11
369
3717
47
115
324
3579
59
229
292
3293
Bacteria identified in Blood by Culture
600-7 [3023368]
2.8e-01
1.1e+00
—
1.0e+50
—
1.6e+00
9.4e-01
cases:1.87%
controls:1.42%
cases:2.14%
controls:0.72%
—
—
cases:1.34%
controls:0.00%
—
—
cases:2.70%
controls:0.54%
cases:5.70%
controls:2.30%
7
53
367
3679
8
27
366
3705
—
5
0
369
3732
—
10
20
361
3674
20
81
331
3441
propranolol; oral, parenteral
C07AA05 [21601670]
5.3e-01
1.5e+00
1.6e+00
—
—
1.1e+00
6.2e-01
cases:4.01%
controls:2.41%
cases:4.01%
controls:0.96%
cases:1.34%
controls:0.27%
—
—
—
—
cases:4.04%
controls:1.38%
cases:4.56%
controls:2.50%
15
90
359
3642
15
36
359
3696
5
10
369
3722
—
—
15
51
356
3643
16
88
335
3434
Cystatin C [Mass/volume] in Serum or Plasma
33863-2 [3030366]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.84%
controls:0.40%
—
—
—
—
—
—
17
14
334
3508
Bell palsy
G51.0 [45571815]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.71%
controls:0.14%
—
—
—
—
—
—
6
5
345
3517
EKG study
11524-6 [3013512]
2.4e-01
3.9e-01
—
—
2.5e+00
2.7e-01
-3.7e-01
cases:1.87%
controls:1.47%
cases:1.34%
controls:0.91%
—
—
—
—
cases:1.60%
controls:0.13%
cases:1.35%
controls:1.03%
cases:2.56%
controls:3.66%
7
55
367
3677
5
34
369
3698
—
—
6
5
368
3723
5
38
366
3656
9
129
342
3393
imiquimod
D06BB10 [21602092]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.99%
controls:0.17%
—
—
—
—
—
—
7
6
344
3516
fluconazole; oral, parenteral
J02AC01 [21603080]
8.2e-01
1.6e+00
1.8e+00
—
—
9.5e-01
4.0e-01
cases:9.36%
controls:4.34%
cases:6.15%
controls:1.29%
cases:1.34%
controls:0.21%
—
—
—
—
cases:2.70%
controls:1.06%
cases:5.70%
controls:3.89%
35
162
339
3570
23
48
351
3684
5
8
369
3724
—
—
10
39
361
3655
20
137
331
3385
Erythrocytes [Presence] in Urine
33051-4 [3045424]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.13%
controls:0.28%
—
—
—
—
—
—
11
10
340
3512
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
-2.4e-01
1.1e+00
—
—
—
1.6e+00
8.7e-01
cases:1.60%
controls:2.04%
cases:2.67%
controls:0.91%
—
—
—
—
—
—
cases:3.23%
controls:0.70%
cases:7.12%
controls:3.12%
6
76
368
3656
10
34
364
3698
—
—
—
12
26
359
3668
25
110
326
3412
imidazoles/triazoles in combination with corticosteroids
D01AC20 [21601936]
1.0e+00
1.4e+00
—
—
—
1.3e+00
-4.1e-02
cases:6.15%
controls:2.36%
cases:3.21%
controls:0.80%
—
—
—
—
—
—
cases:2.43%
controls:0.65%
cases:2.56%
controls:2.67%
23
88
351
3644
12
30
362
3702
—
—
—
9
24
362
3670
9
94
342
3428
Hepatitis A virus Ab [Presence] in Serum
20575-7 [3016650]
—
—
1.0e+50
—
1.0e+50
—
2.3e+00
—
—
—
—
cases:1.34%
controls:0.00%
—
—
cases:1.87%
controls:0.00%
—
—
cases:1.99%
controls:0.20%
—
—
5
0
369
3732
—
7
0
367
3728
—
7
7
344
3515
Fracture of upper end of humerus
S42.2 [45544677]
-1.0e+50
—
—
—
—
—
2.3e+00
cases:0.00%
controls:0.21%
—
—
—
—
—
—
—
—
—
—
cases:1.71%
controls:0.17%
0
8
374
3724
—
—
—
—
—
6
6
345
3516
Anoscopy
UJH02 [2001305182]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.71%
controls:0.17%
—
—
—
—
—
—
6
6
345
3516
Zoster without complication
B02.9 [45581143]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.71%
controls:0.17%
—
—
—
—
—
—
6
6
345
3516
Biopsy of skin and subcutaneous tissue
TQX10 [2001310152]
—
—
—
—
—
2.3e+00
2.3e+00
—
—
—
—
—
—
—
—
—
—
cases:1.35%
controls:0.14%
cases:4.27%
controls:0.45%
—
—
—
—
—
5
5
366
3689
15
16
336
3506
One hour or less
ZXE00 [2001311394]
5.1e-01
1.1e+00
—
—
—
1.2e+00
1.1e+00
cases:5.88%
controls:3.62%
cases:2.41%
controls:0.83%
—
—
—
—
—
—
cases:3.50%
controls:1.06%
cases:9.69%
controls:3.61%
22
135
352
3597
9
31
365
3701
—
—
—
13
39
358
3655
34
127
317
3395
General Practice Dentistry
1223G0001X [38003675]
-1.0e+50
—
—
—
—
—
2.2e+00
cases:0.00%
controls:0.19%
—
—
—
—
—
—
—
—
—
—
cases:3.13%
controls:0.34%
0
7
374
3725
—
—
—
—
—
11
12
340
3510
Depressive episode
F32 [45595904]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.28%
controls:0.26%
—
—
—
—
—
—
8
9
343
3513
Ultrasound examination of uterus and parametria
LC2AE [2001306543]
2.2e+00
—
—
—
—
—
—
cases:1.87%
controls:0.21%
—
—
—
—
—
—
—
—
—
—
—
—
7
8
367
3724
—
—
—
—
—
—
Other gastroenteritis and colitis of infectious and unspecified origin
A09 [45605189]
1.1e+00
1.5e+00
—
—
—
—
1.1e+00
cases:3.74%
controls:1.29%
cases:1.60%
controls:0.38%
—
—
—
—
—
—
—
—
cases:5.13%
controls:1.79%
14
48
360
3684
6
14
368
3718
—
—
—
—
18
63
333
3459
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
-3.0e-01
—
2.2e+00
—
—
1.0e+00
3.6e-01
cases:1.87%
controls:2.52%
—
—
cases:1.60%
controls:0.19%
—
—
—
—
cases:3.23%
controls:1.19%
cases:8.55%
controls:6.13%
7
94
367
3638
—
6
7
368
3725
—
—
12
44
359
3650
30
216
321
3306
amphotericin B; oral
A07AA07 [21600609]
2.2e+00
—
—
—
—
—
—
cases:1.60%
controls:0.19%
—
—
—
—
—
—
—
—
—
—
—
—
6
7
368
3725
—
—
—
—
—
—
quetiapine; oral
N05AH04 [21604544]
9.1e-01
6.5e-01
—
—
—
1.1e+00
1.0e+00
cases:4.55%
controls:1.88%
cases:2.94%
controls:1.55%
—
—
—
—
—
—
cases:4.85%
controls:1.68%
cases:7.98%
controls:3.04%
17
70
357
3662
11
58
363
3674
—
—
—
18
62
353
3632
28
107
323
3415
hydrocortisone
S02BA01 [21605166]
9.5e-01
1.1e+00
—
—
—
7.8e-01
3.6e-01
cases:10.16%
controls:4.21%
cases:4.81%
controls:1.58%
—
—
—
—
—
—
cases:3.23%
controls:1.52%
cases:6.55%
controls:4.68%
38
157
336
3575
18
59
356
3673
—
—
—
12
56
359
3638
23
165
328
3357
Lumbar puncture
TAB00 [2001300538]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.85%
controls:0.37%
—
—
—
—
—
—
10
13
341
3509
hydrocortisone
D07AA02 [21602102]
1.0e+00
1.0e+00
—
—
—
8.4e-01
3.8e-01
cases:12.30%
controls:4.82%
cases:4.81%
controls:1.77%
—
—
—
—
—
—
cases:4.04%
controls:1.79%
cases:7.69%
controls:5.37%
46
180
328
3552
18
66
356
3666
—
—
—
15
66
356
3628
27
189
324
3333
hydrocortisone butyrate
D07AB02 [21602106]
1.0e+00
1.0e+00
—
—
—
8.4e-01
3.8e-01
cases:12.30%
controls:4.82%
cases:4.81%
controls:1.77%
—
—
—
—
—
—
cases:4.04%
controls:1.79%
cases:7.69%
controls:5.37%
46
180
328
3552
18
66
356
3666
—
—
—
15
66
356
3628
27
189
324
3333
hydrocortisone buteprate
D07AB11 [21602115]
1.0e+00
1.0e+00
—
—
—
8.4e-01
3.8e-01
cases:12.30%
controls:4.82%
cases:4.81%
controls:1.77%
—
—
—
—
—
—
cases:4.04%
controls:1.79%
cases:7.69%
controls:5.37%
46
180
328
3552
18
66
356
3666
—
—
—
15
66
356
3628
27
189
324
3333
hydrocortisone aceponate
D07AC16 [21602135]
1.0e+00
1.0e+00
—
—
—
8.4e-01
3.8e-01
cases:12.30%
controls:4.82%
cases:4.81%
controls:1.77%
—
—
—
—
—
—
cases:4.04%
controls:1.79%
cases:7.69%
controls:5.37%
46
180
328
3552
18
66
356
3666
—
—
—
15
66
356
3628
27
189
324
3333
citalopram; oral, parenteral
N06AB04 [21604712]
9.8e-01
1.1e+00
—
—
—
9.4e-01
7.9e-01
cases:7.75%
controls:3.05%
cases:4.28%
controls:1.53%
—
—
—
—
—
—
cases:4.04%
controls:1.62%
cases:5.98%
controls:2.81%
29
114
345
3618
16
57
358
3675
—
—
—
15
60
356
3634
21
99
330
3423
hydrocortisone
C05AA01 [21601608]
1.0e+00
1.0e+00
—
—
—
8.2e-01
4.1e-01
cases:12.30%
controls:4.88%
cases:4.81%
controls:1.77%
—
—
—
—
—
—
cases:4.04%
controls:1.81%
cases:7.98%
controls:5.42%
46
182
328
3550
18
66
356
3666
—
—
—
15
67
356
3627
28
191
323
3331
hydrocortisone
A07EA02 [21600654]
1.0e+00
1.0e+00
—
—
—
8.2e-01
4.1e-01
cases:12.30%
controls:4.88%
cases:4.81%
controls:1.77%
—
—
—
—
—
—
cases:4.04%
controls:1.81%
cases:7.98%
controls:5.42%
46
182
328
3550
18
66
356
3666
—
—
—
15
67
356
3627
28
191
323
3331
Insertion of intrauterine device
TLC00 [2001306647]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.71%
controls:0.23%
—
—
—
—
—
—
6
8
345
3514
levomepromazine; oral, parenteral
N05AA02 [21604493]
1.0e+00
—
—
—
—
1.7e+00
2.0e+00
cases:1.34%
controls:0.48%
—
—
—
—
—
—
—
—
cases:1.35%
controls:0.24%
cases:2.85%
controls:0.40%
5
18
369
3714
—
—
—
—
5
9
366
3685
10
14
341
3508
Midwife
Z3232 [2001311563]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.99%
controls:0.57%
—
—
—
—
—
—
14
20
337
3502
Dental examination
Z01.2 [45581002]
6.5e-01
4.2e-01
—
—
-1.0e+50
1.1e+00
8.5e-01
cases:4.81%
controls:2.57%
cases:1.87%
controls:1.23%
—
—
—
—
cases:0.00%
controls:0.19%
cases:4.58%
controls:1.54%
cases:15.38%
controls:7.18%
18
96
356
3636
7
46
367
3686
—
—
0
7
374
3721
17
57
354
3637
54
253
297
3269
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
-2.8e-01
8.9e-01
—
—
—
1.9e+00
7.4e-01
cases:1.34%
controls:1.77%
cases:1.87%
controls:0.78%
—
—
—
—
—
—
cases:2.70%
controls:0.41%
cases:5.98%
controls:2.95%
5
66
369
3666
7
29
367
3703
—
—
—
10
15
361
3679
21
104
330
3418
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
X69 [45585661]
1.9e+00
—
—
—
—
—
—
cases:2.14%
controls:0.32%
—
—
—
—
—
—
—
—
—
—
—
—
8
12
366
3720
—
—
—
—
—
—
Erysipelas
A46 [45561706]
7.3e-01
—
—
—
—
1.9e+00
1.1e+00
cases:1.60%
controls:0.78%
—
—
—
—
—
—
—
—
cases:2.16%
controls:0.32%
cases:3.42%
controls:1.14%
6
29
368
3703
—
—
—
—
8
12
363
3682
12
40
339
3482
Leukocytes [Presence] in Urine
33052-2 [3045414]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.70%
controls:0.57%
—
—
—
—
—
—
13
20
338
3502
Hepatitis B virus core and surface Ab and surface Ag panel - Serum
77190-7 [46237023]
—
—
—
—
1.0e+50
—
1.9e+00
—
—
—
—
—
—
—
—
cases:1.87%
controls:0.00%
—
—
cases:1.99%
controls:0.31%
—
—
—
—
7
0
367
3728
—
7
11
344
3511
Other specified chronic obstructive pulmonary disease
J44.8 [45586673]
1.0e+00
—
—
1.0e+50
—
1.9e+00
1.2e+00
cases:1.34%
controls:0.48%
—
—
—
—
cases:1.87%
controls:0.00%
—
—
cases:1.89%
controls:0.30%
cases:2.56%
controls:0.80%
5
18
369
3714
—
—
7
0
367
3732
—
7
11
364
3683
9
28
342
3494
Fungus identified in Specimen by Culture
580-1 [3000494]
—
—
—
—
—
1.9e+00
1.1e+00
—
—
—
—
—
—
—
—
—
—
cases:1.89%
controls:0.30%
cases:2.85%
controls:0.99%
—
—
—
—
—
7
11
364
3683
10
35
341
3487
Recurrent depression, moderate episode without somatic syndrome
F33.10 [2000501984]
—
—
—
—
—
2.1e+00
1.8e+00
—
—
—
—
—
—
—
—
—
—
cases:1.35%
controls:0.16%
cases:2.28%
controls:0.37%
—
—
—
—
—
5
6
366
3688
8
13
343
3509
Verruca simplex
B07.9 [2000500357]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.28%
controls:0.37%
—
—
—
—
—
—
8
13
343
3509
lorazepam; oral, parenteral, sublingual
N05BA06 [21604571]
—
—
—
—
—
1.6e+00
1.8e+00
—
—
—
—
—
—
—
—
—
—
cases:1.35%
controls:0.27%
cases:2.28%
controls:0.37%
—
—
—
—
—
5
10
366
3684
8
13
343
3509
escitalopram; oral
N06AB10 [21604718]
9.4e-01
8.6e-01
—
—
1.4e+00
8.9e-01
8.9e-01
cases:6.68%
controls:2.73%
cases:4.01%
controls:1.74%
—
—
—
—
cases:1.34%
controls:0.35%
cases:4.31%
controls:1.81%
cases:7.12%
controls:3.07%
25
102
349
3630
15
65
359
3667
—
—
5
13
369
3715
16
67
355
3627
25
108
326
3414
Extensive abdominal CT
JN3BD [2001305556]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.70%
controls:0.62%
—
—
—
—
—
—
13
22
338
3500
Hand and fingers X-ray examination
ND2AA [2001307607]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.85%
controls:0.48%
—
—
—
—
—
—
10
17
341
3505
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 [21602863]
4.5e-01
1.1e+00
—
—
—
5.1e-01
6.0e-01
cases:9.36%
controls:6.19%
cases:5.61%
controls:1.85%
—
—
—
—
—
—
cases:3.77%
controls:2.30%
cases:13.39%
controls:7.81%
35
231
339
3501
21
69
353
3663
—
—
—
14
85
357
3609
47
275
304
3247
fluoxetine; oral
N06AB03 [21604711]
5.6e-01
1.1e+00
—
—
—
1.7e+00
1.3e+00
cases:2.14%
controls:1.23%
cases:1.87%
controls:0.62%
—
—
—
—
—
—
cases:2.70%
controls:0.49%
cases:2.85%
controls:0.80%
8
46
366
3686
7
23
367
3709
—
—
—
10
18
361
3676
10
28
341
3494
loperamide; oral
A07DA03 [21600646]
—
—
—
—
—
-1.0e+50
1.7e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.22%
cases:3.42%
controls:0.62%
—
—
—
—
—
0
8
371
3686
12
22
339
3500
loperamide oxide; oral
A07DA05 [21600648]
—
—
—
—
—
-1.0e+50
1.7e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.22%
cases:3.42%
controls:0.62%
—
—
—
—
—
0
8
371
3686
12
22
339
3500
pravastatin; oral
C10AA03 [21601858]
—
—
—
—
—
—
1.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.56%
controls:0.48%
—
—
—
—
—
—
9
17
342
3505
Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
18500-9 [3018006]
—
—
—
—
—
1.5e+00
1.7e+00
—
—
—
—
—
—
—
—
—
—
cases:1.35%
controls:0.30%
cases:4.27%
controls:0.82%
—
—
—
—
—
5
11
366
3683
15
29
336
3493
Dental calculus supragingival
K03.64 [2000502689]
1.6e-01
—
—
—
—
1.7e+00
4.7e-01
cases:2.14%
controls:1.82%
—
—
—
—
—
—
—
—
cases:2.96%
controls:0.57%
cases:6.55%
controls:4.20%
8
68
366
3664
—
—
—
—
11
21
360
3673
23
148
328
3374
Upper gastrointestinal surgery
106 [44777669]
5.2e-01
7.9e-01
1.8e+00
—
—
9.1e-01
7.6e-01
cases:7.49%
controls:4.61%
cases:3.48%
controls:1.61%
cases:1.34%
controls:0.21%
—
—
—
—
cases:4.85%
controls:2.00%
cases:11.40%
controls:5.68%
28
172
346
3560
13
60
361
3672
5
8
369
3724
—
—
18
74
353
3620
40
200
311
3322
Home Visit
OMOP4822459 [581476]
-1.0e+50
—
—
—
—
1.6e+00
1.4e-01
cases:0.00%
controls:1.18%
—
—
—
—
—
—
—
—
cases:3.23%
controls:0.65%
cases:3.70%
controls:3.24%
0
44
374
3688
—
—
—
—
12
24
359
3670
13
114
338
3408
Malaise and fatigue
R53 [45553741]
5.8e-01
1.1e+00
—
—
—
1.6e+00
1.9e-01
cases:1.34%
controls:0.75%
cases:1.60%
controls:0.54%
—
—
—
—
—
—
cases:2.16%
controls:0.43%
cases:1.99%
controls:1.65%
5
28
369
3704
6
20
368
3712
—
—
—
8
16
363
3678
7
58
344
3464
Periodontal treatment by dental hygienist, very extensive
SDE04 [2001310352]
—
-1.0e+50
—
—
—
1.7e+00
1.6e+00
—
—
cases:0.00%
controls:0.32%
—
—
—
—
—
—
cases:1.35%
controls:0.24%
cases:3.99%
controls:0.85%
—
0
12
374
3720
—
—
—
5
9
366
3685
14
30
337
3492
antibiotics in combination with corticosteroids
D01AA20 [21601918]
1.5e+00
—
—
—
—
—
7.1e-01
cases:2.94%
controls:0.64%
—
—
—
—
—
—
—
—
—
—
cases:1.71%
controls:0.85%
11
24
363
3708
—
—
—
—
—
6
30
345
3492
Headache
N01 [2002000720]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.85%
controls:0.62%
—
—
—
—
—
—
10
22
341
3500
Mixed anxiety and depressive disorder
F41.2 [45566845]
1.4e+00
—
—
—
—
—
1.5e+00
cases:1.87%
controls:0.46%
—
—
—
—
—
—
—
—
—
—
cases:3.42%
controls:0.77%
7
17
367
3715
—
—
—
—
—
12
27
339
3495
Chronic apical periodontitis
K04.5 [45586691]
4.0e-01
—
—
—
-1.0e+50
1.5e+00
5.7e-01
cases:2.14%
controls:1.45%
—
—
—
—
—
—
cases:0.00%
controls:0.19%
cases:2.96%
controls:0.68%
cases:5.41%
controls:3.12%
8
54
366
3678
—
—
—
0
7
374
3721
11
25
360
3669
19
110
332
3412
azithromycin; oral, parenteral
J01FA10 [21602978]
5.7e-01
9.3e-01
—
—
—
2.8e-01
-2.5e-01
cases:14.44%
controls:8.74%
cases:5.61%
controls:2.30%
—
—
—
—
—
—
cases:3.77%
controls:2.87%
cases:7.41%
controls:9.28%
54
326
320
3406
21
86
353
3646
—
—
—
14
106
357
3588
26
327
325
3195
ranitidine; oral, parenteral
A02BA02 [21600083]
3.8e-01
—
—
—
—
1.2e+00
1.5e+00
cases:1.87%
controls:1.29%
—
—
—
—
—
—
—
—
cases:1.35%
controls:0.41%
cases:3.99%
controls:0.94%
7
48
367
3684
—
—
—
—
5
15
366
3679
14
33
337
3489
ranitidine bismuth citrate; oral
A02BA07 [21600088]
3.8e-01
—
—
—
—
1.2e+00
1.5e+00
cases:1.87%
controls:1.29%
—
—
—
—
—
—
—
—
cases:1.35%
controls:0.41%
cases:3.99%
controls:0.94%
7
48
367
3684
—
—
—
—
5
15
366
3679
14
33
337
3489
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
—
-1.0e+50
—
—
—
—
1.5e+00
—
—
cases:0.00%
controls:0.19%
—
—
—
—
—
—
—
—
cases:2.56%
controls:0.60%
—
0
7
374
3725
—
—
—
—
9
21
342
3501
Bacterial infection, unspecified
A49.9 [45590816]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.56%
controls:0.60%
—
—
—
—
—
—
9
21
342
3501
Periodontitis pronounced
K05.31 [2000502729]
—
—
—
—
—
—
1.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.42%
controls:0.82%
—
—
—
—
—
—
12
29
339
3493
Periodontitis complex
K05.30 [2000502728]
-1.0e+50
—
—
—
—
2.0e+00
1.4e+00
cases:0.00%
controls:0.56%
—
—
—
—
—
—
—
—
cases:1.35%
controls:0.19%
cases:4.84%
controls:1.19%
0
21
374
3711
—
—
—
—
5
7
366
3687
17
42
334
3480
cefalexin; oral
J01DB01 [21602870]
4.4e-01
9.8e-01
9.9e-01
—
1.0e+00
4.7e-01
3.9e-01
cases:34.76%
controls:25.51%
cases:18.98%
controls:8.07%
cases:2.41%
controls:0.91%
—
—
cases:2.41%
controls:0.86%
cases:11.86%
controls:7.74%
cases:34.76%
controls:26.60%
130
952
244
2780
71
301
303
3431
9
34
365
3698
—
9
32
365
3696
44
286
327
3408
122
937
229
2585
More than one and less than three hours
ZXE10 [2001311401]
3.0e-02
1.1e+00
—
—
—
1.2e+00
1.4e+00
cases:3.48%
controls:3.38%
cases:2.14%
controls:0.75%
—
—
—
—
—
—
cases:2.96%
controls:0.89%
cases:10.26%
controls:2.73%
13
126
361
3606
8
28
366
3704
—
—
—
11
33
360
3661
36
96
315
3426
Hyaline casts [#/volume] in Urine by Automated count
51484-4 [3030981]
—
-1.0e+50
—
—
—
—
1.4e+00
—
—
cases:0.00%
controls:0.32%
—
—
—
—
—
—
—
—
cases:3.13%
controls:0.80%
—
0
12
374
3720
—
—
—
—
11
28
340
3494
moxifloxacin; oral, parenteral
J01MA14 [21603021]
—
—
—
—
—
—
1.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.85%
controls:0.74%
—
—
—
—
—
—
10
26
341
3496
More than three and less than five hours
ZXE20 [2001311408]
—
—
—
—
—
-1.0e+50
1.4e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.22%
cases:2.85%
controls:0.74%
—
—
—
—
—
0
8
371
3686
10
26
341
3496
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
—
—
—
—
—
1.0e+00
1.4e+00
—
—
—
—
—
—
—
—
—
—
cases:1.62%
controls:0.60%
cases:6.84%
controls:1.85%
—
—
—
—
—
6
22
365
3672
24
65
327
3457
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]
5.7e-01
1.4e+00
—
—
—
—
4.9e-01
cases:4.01%
controls:2.30%
cases:2.94%
controls:0.78%
—
—
—
—
—
—
—
—
cases:5.13%
controls:3.21%
15
86
359
3646
11
29
363
3703
—
—
—
—
18
113
333
3409
Intravenous general anesthesia
WX404 [2001310807]
1.6e-01
—
—
—
—
1.5e+00
1.4e+00
cases:1.60%
controls:1.37%
—
—
—
—
—
—
—
—
cases:1.35%
controls:0.30%
cases:4.56%
controls:1.22%
6
51
368
3681
—
—
—
—
5
11
366
3683
16
43
335
3479
Periodontal treatment, brief
SDA02 [2001310327]
-1.8e-01
—
—
—
—
1.4e+00
5.5e-01
cases:1.87%
controls:2.22%
—
—
—
—
—
—
—
—
cases:2.96%
controls:0.79%
cases:7.12%
controls:4.23%
7
83
367
3649
—
—
—
—
11
29
360
3665
25
149
326
3373
Gingivitis (chronic) NOS
K05.10 [2000502717]
1.4e+00
1.6e+00
—
—
—
1.7e+00
1.3e+00
cases:1.87%
controls:0.46%
cases:1.34%
controls:0.27%
—
—
—
—
—
—
cases:1.62%
controls:0.30%
cases:5.41%
controls:1.48%
7
17
367
3715
5
10
369
3722
—
—
—
6
11
365
3683
19
52
332
3470
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
—
8.4e-01
1.5e+00
—
—
1.3e+00
6.9e-01
—
—
cases:1.60%
controls:0.70%
cases:1.34%
controls:0.29%
—
—
—
—
cases:3.50%
controls:0.95%
cases:6.55%
controls:3.41%
—
6
26
368
3706
5
11
369
3721
—
—
13
35
358
3659
23
120
328
3402
lymecycline; oral, parenteral
J01AA04 [21602802]
1.3e+00
—
—
—
—
—
—
cases:4.01%
controls:1.13%
—
—
—
—
—
—
—
—
—
—
—
—
15
42
359
3690
—
—
—
—
—
—
Osmolality of Urine
2695-5 [3026782]
—
—
—
—
—
1.3e+00
1.3e+00
—
—
—
—
—
—
—
—
—
—
cases:1.89%
controls:0.51%
cases:6.27%
controls:1.82%
—
—
—
—
—
7
19
364
3675
22
64
329
3458
Hyperlipidaemia, unspecified
E78.5 [45537986]
—
—
—
—
—
1.7e+00
1.3e+00
—
—
—
—
—
—
—
—
—
—
cases:1.35%
controls:0.24%
cases:4.56%
controls:1.31%
—
—
—
—
—
5
9
366
3685
16
46
335
3476
aciclovir; oral, parenteral
J05AB01 [21603131]
1.3e+00
1.3e+00
—
—
—
9.2e-01
8.2e-01
cases:6.68%
controls:1.96%
cases:2.41%
controls:0.70%
—
—
—
—
—
—
cases:1.62%
controls:0.65%
cases:4.84%
controls:2.19%
25
73
349
3659
9
26
365
3706
—
—
—
6
24
365
3670
17
77
334
3445
triamcinolone and antiseptics
D07BB03 [21602150]
1.3e+00
1.1e+00
—
—
—
1.3e+00
3.5e-03
cases:4.01%
controls:1.15%
cases:1.34%
controls:0.46%
—
—
—
—
—
—
cases:1.35%
controls:0.38%
cases:1.71%
controls:1.70%
15
43
359
3689
5
17
369
3715
—
—
—
5
14
366
3680
6
60
345
3462
Sedation and analgesia
WX002 [2001310758]
—
—
—
—
—
—
1.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.42%
controls:0.99%
—
—
—
—
—
—
12
35
339
3487
Deposits [accretions] on teeth betel
K03.65 [2000502690]
3.8e-01
—
—
—
—
—
1.3e+00
cases:1.60%
controls:1.10%
—
—
—
—
—
—
—
—
—
—
cases:8.26%
controls:2.50%
6
41
368
3691
—
—
—
—
—
29
88
322
3434
venlafaxine; oral
N06AX16 [21604745]
8.7e-01
8.7e-01
—
—
—
5.5e-01
1.2e+00
cases:2.94%
controls:1.26%
cases:1.34%
controls:0.56%
—
—
—
—
—
—
cases:1.35%
controls:0.79%
cases:4.56%
controls:1.36%
11
47
363
3685
5
21
369
3711
—
—
—
5
29
366
3665
16
48
335
3474
Diarrhoea
D11 [2002000310]
—
—
—
—
—
—
1.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.99%
controls:1.22%
—
—
—
—
—
—
14
43
337
3479
chlorhexidine
S03AA04 [21605193]
1.2e+00
1.1e+00
—
—
—
1.3e+00
2.1e-02
cases:3.74%
controls:1.15%
cases:1.34%
controls:0.46%
—
—
—
—
—
—
cases:1.35%
controls:0.38%
cases:1.71%
controls:1.68%
14
43
360
3689
5
17
369
3715
—
—
—
5
14
366
3680
6
59
345
3463
chlorhexidine
D09AA12 [21602275]
1.2e+00
1.1e+00
—
—
—
1.3e+00
2.1e-02
cases:3.74%
controls:1.15%
cases:1.34%
controls:0.46%
—
—
—
—
—
—
cases:1.35%
controls:0.38%
cases:1.71%
controls:1.68%
14
43
360
3689
5
17
369
3715
—
—
—
5
14
366
3680
6
59
345
3463
hydrocortisone and antiseptics
D07BA04 [21602146]
1.2e+00
1.1e+00
—
—
—
1.3e+00
2.1e-02
cases:3.74%
controls:1.15%
cases:1.34%
controls:0.46%
—
—
—
—
—
—
cases:1.35%
controls:0.38%
cases:1.71%
controls:1.68%
14
43
360
3689
5
17
369
3715
—
—
—
5
14
366
3680
6
59
345
3463
chlorhexidine, combinations
D08AC52 [21602208]
1.2e+00
1.1e+00
—
—
—
1.3e+00
2.1e-02
cases:3.74%
controls:1.15%
cases:1.34%
controls:0.46%
—
—
—
—
—
—
cases:1.35%
controls:0.38%
cases:1.71%
controls:1.68%
14
43
360
3689
5
17
369
3715
—
—
—
5
14
366
3680
6
59
345
3463
other antifungals for topical use - combinations; ointment
D01AE20 [21601959]
1.2e+00
1.1e+00
—
—
—
1.3e+00
2.1e-02
cases:3.74%
controls:1.15%
cases:1.34%
controls:0.46%
—
—
—
—
—
—
cases:1.35%
controls:0.38%
cases:1.71%
controls:1.68%
14
43
360
3689
5
17
369
3715
—
—
—
5
14
366
3680
6
59
345
3463
chlorhexidine
S02AA09 [21605155]
1.2e+00
1.1e+00
—
—
—
1.3e+00
2.1e-02
cases:3.74%
controls:1.15%
cases:1.34%
controls:0.46%
—
—
—
—
—
—
cases:1.35%
controls:0.38%
cases:1.71%
controls:1.68%
14
43
360
3689
5
17
369
3715
—
—
—
5
14
366
3680
6
59
345
3463
hydrocortisone
D07XA01 [21602180]
1.2e+00
1.1e+00
—
—
—
1.3e+00
2.1e-02
cases:3.74%
controls:1.15%
cases:1.34%
controls:0.46%
—
—
—
—
—
—
cases:1.35%
controls:0.38%
cases:1.71%
controls:1.68%
14
43
360
3689
5
17
369
3715
—
—
—
5
14
366
3680
6
59
345
3463
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
1.2e+00
1.5e+00
—
—
—
1.1e+00
3.8e-02
cases:3.48%
controls:1.07%
cases:2.14%
controls:0.51%
—
—
—
—
—
—
cases:1.35%
controls:0.46%
cases:2.56%
controls:2.47%
13
40
361
3692
8
19
366
3713
—
—
—
5
17
366
3677
9
87
342
3435
Bacteria [Presence] in Urine
87829-8 [36304419]
4.9e-01
—
2.3e+00
—
—
1.2e+00
1.2e+00
cases:2.67%
controls:1.66%
—
—
cases:1.34%
controls:0.13%
—
—
—
—
cases:2.70%
controls:0.84%
cases:7.41%
controls:2.36%
10
62
364
3670
—
5
5
369
3727
—
—
10
31
361
3663
26
83
325
3439
zolpidem; oral
N05CF02 [21604655]
5.8e-01
8.5e-01
—
—
2.0e+00
9.0e-01
1.2e+00
cases:3.21%
controls:1.82%
cases:2.41%
controls:1.05%
—
—
—
—
cases:1.34%
controls:0.19%
cases:2.70%
controls:1.11%
cases:7.12%
controls:2.36%
12
68
362
3664
9
39
365
3693
—
—
5
7
369
3721
10
41
361
3653
25
83
326
3439
Person consulting for explanation of investigation findings
Z71.2 [45552100]
5.4e-01
1.0e+00
—
—
—
4.2e-01
1.1e+00
cases:2.41%
controls:1.42%
cases:1.34%
controls:0.48%
—
—
—
—
—
—
cases:1.35%
controls:0.89%
cases:7.69%
controls:2.70%
9
53
365
3679
5
18
369
3714
—
—
—
5
33
366
3661
27
95
324
3427
beclometasone; inhalant
R03BA01 [21603284]
1.1e+00
3.9e-01
—
—
—
4.2e-01
6.1e-01
cases:4.01%
controls:1.39%
cases:1.34%
controls:0.91%
—
—
—
—
—
—
cases:1.35%
controls:0.89%
cases:3.13%
controls:1.73%
15
52
359
3680
5
34
369
3698
—
—
—
5
33
366
3661
11
61
340
3461
Acute bronchitis, unspecified
J20.9 [45562445]
-2.2e-03
—
—
—
—
—
1.1e+00
cases:1.34%
controls:1.34%
—
—
—
—
—
—
—
—
—
—
cases:5.41%
controls:1.90%
5
50
369
3682
—
—
—
—
—
19
67
332
3455
roxithromycin; oral
J01FA06 [21602974]
3.5e-01
1.1e+00
—
—
—
-4.4e-02
5.9e-01
cases:6.68%
controls:4.82%
cases:3.74%
controls:1.31%
—
—
—
—
—
—
cases:1.35%
controls:1.41%
cases:6.55%
controls:3.75%
25
180
349
3552
14
49
360
3683
—
—
—
5
52
366
3642
23
132
328
3390
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
—
—
—
—
—
1.2e+00
1.1e+00
—
—
—
—
—
—
—
—
—
—
cases:2.96%
controls:0.95%
cases:10.54%
controls:3.95%
—
—
—
—
—
11
35
360
3659
37
139
314
3383
omeprazole; oral, parenteral
A02BC01 [21600096]
5.7e-01
1.3e+00
—
—
—
7.6e-01
1.0e+00
cases:4.55%
controls:2.63%
cases:2.67%
controls:0.75%
—
—
—
—
—
—
cases:1.89%
controls:0.89%
cases:5.70%
controls:2.10%
17
98
357
3634
10
28
364
3704
—
—
—
7
33
364
3661
20
74
331
3448
cetirizine; oral
R06AE07 [21603497]
4.7e-01
5.3e-01
—
—
—
7.8e-01
1.0e+00
cases:9.63%
controls:6.22%
cases:4.81%
controls:2.89%
—
—
—
—
—
—
cases:5.39%
controls:2.54%
cases:16.52%
controls:6.64%
36
232
338
3500
18
108
356
3624
—
—
—
20
94
351
3600
58
234
293
3288
Other and unspecified abdominal pain
R10.4 [45568113]
6.1e-01
7.0e-01
—
—
—
9.5e-01
9.9e-01
cases:5.08%
controls:2.81%
cases:1.87%
controls:0.94%
—
—
—
—
—
—
cases:2.43%
controls:0.95%
cases:8.26%
controls:3.24%
19
105
355
3627
7
35
367
3697
—
—
—
9
35
362
3659
29
114
322
3408
Treatment plan or consultation
WZC00 [2001310885]
-9.9e-02
—
—
—
—
1.3e+00
9.3e-01
cases:1.87%
controls:2.06%
—
—
—
—
—
—
—
—
cases:2.43%
controls:0.68%
cases:7.98%
controls:3.29%
7
77
367
3655
—
—
—
—
9
25
362
3669
28
116
323
3406
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
9.2e-01
6.6e-01
—
—
—
9.9e-01
4.9e-01
cases:9.36%
controls:3.94%
cases:2.67%
controls:1.39%
—
—
—
—
—
—
cases:3.77%
controls:1.43%
cases:6.84%
controls:4.29%
35
147
339
3585
10
52
364
3680
—
—
—
14
53
357
3641
24
151
327
3371
orphenadrine, combinations
M03BC51 [21604113]
9.0e-01
4.2e-01
-1.0e+50
—
-1.0e+50
6.6e-01
-3.3e-02
cases:6.42%
controls:2.71%
cases:1.34%
controls:0.88%
cases:0.00%
controls:0.19%
—
—
cases:0.00%
controls:0.13%
cases:1.62%
controls:0.84%
cases:3.99%
controls:4.12%
24
101
350
3631
5
33
369
3699
0
7
374
3725
—
0
5
374
3723
6
31
365
3663
14
145
337
3377
Caries of dentine
K02.1 [45548134]
7.3e-02
1.2e-01
9.7e-01
—
1.5e+00
9.0e-01
4.2e-01
cases:6.68%
controls:6.24%
cases:3.74%
controls:3.35%
cases:1.34%
controls:0.51%
—
—
cases:1.87%
controls:0.43%
cases:7.82%
controls:3.33%
cases:22.51%
controls:16.01%
25
233
349
3499
14
125
360
3607
5
19
369
3713
—
7
16
367
3712
29
123
342
3571
79
564
272
2958
Neurology
13 [38004458]
1.4e-01
-2.3e-02
—
—
—
8.9e-01
5.2e-01
cases:6.95%
controls:6.11%
cases:2.67%
controls:2.73%
—
—
—
—
—
—
cases:5.93%
controls:2.52%
cases:11.40%
controls:7.13%
26
228
348
3504
10
102
364
3630
—
—
—
22
93
349
3601
40
251
311
3271
Otolaryngology
4 [38004449]
2.1e-01
8.9e-01
1.6e+00
—
—
6.2e-01
3.0e-01
cases:9.36%
controls:7.72%
cases:6.42%
controls:2.73%
cases:1.60%
controls:0.32%
—
—
—
—
cases:5.39%
controls:2.98%
cases:11.40%
controls:8.72%
35
288
339
3444
24
102
350
3630
6
12
368
3720
—
—
20
110
351
3584
40
307
311
3215
Other specified counselling
Z71.8 [45581061]
6.9e-01
—
—
—
—
1.1e+00
8.9e-01
cases:2.94%
controls:1.50%
—
—
—
—
—
—
—
—
cases:2.70%
controls:0.89%
cases:6.55%
controls:2.81%
11
56
363
3676
—
—
—
—
10
33
361
3661
23
99
328
3423
sildenafil; oral
G04BE03 [21602648]
3.5e-01
1.5e-01
—
—
-1.0e+50
—
8.8e-01
cases:2.41%
controls:1.71%
cases:1.34%
controls:1.15%
—
—
—
—
cases:0.00%
controls:0.16%
—
—
cases:8.55%
controls:3.72%
9
64
365
3668
5
43
369
3689
—
—
0
6
374
3722
—
30
131
321
3391
Upper respiratory infection acute
R74 [2002000942]
5.6e-01
—
-1.0e+50
—
-1.0e+50
3.7e-02
8.8e-01
cases:4.28%
controls:2.49%
—
—
cases:0.00%
controls:0.16%
—
—
cases:0.00%
controls:0.21%
cases:1.35%
controls:1.30%
cases:10.83%
controls:4.80%
16
93
358
3639
—
0
6
374
3726
—
0
8
374
3720
5
48
366
3646
38
169
313
3353
Basic examination of mouth
SAA02 [2001310275]
-2.5e-01
2.1e-01
—
—
—
7.8e-01
7.1e-02
cases:5.88%
controls:7.42%
cases:3.48%
controls:2.84%
—
—
—
—
—
—
cases:6.47%
controls:3.06%
cases:17.38%
controls:16.38%
22
277
352
3455
13
106
361
3626
—
—
—
24
113
347
3581
61
577
290
2945
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
-3.2e-02
4.3e-01
1.1e+00
—
7.0e-01
7.5e-01
1.3e-01
cases:16.31%
controls:16.75%
cases:12.03%
controls:8.20%
cases:3.21%
controls:1.10%
—
—
cases:2.41%
controls:1.21%
cases:17.25%
controls:8.96%
cases:29.06%
controls:26.46%
61
625
313
3107
45
306
329
3426
12
41
362
3691
—
9
45
365
3683
64
331
307
3363
102
932
249
2590
INR in Blood by Coagulation assay
34714-6 [3032080]
3.7e-01
3.9e-01
—
—
1.6e+00
9.2e-01
7.3e-01
cases:3.48%
controls:2.44%
cases:2.41%
controls:1.63%
—
—
—
—
cases:2.14%
controls:0.46%
cases:4.04%
controls:1.65%
cases:8.26%
controls:4.17%
13
91
361
3641
9
61
365
3671
—
—
8
17
366
3711
15
61
356
3633
29
147
322
3375
Periodontal treatment
SDA03 [2001310328]
3.1e-01
2.5e-01
—
—
—
5.6e-01
7.2e-01
cases:3.21%
controls:2.38%
cases:1.34%
controls:1.05%
—
—
—
—
—
—
cases:2.16%
controls:1.25%
cases:9.40%
controls:4.83%
12
89
362
3643
5
39
369
3693
—
—
—
8
46
363
3648
33
170
318
3352
Acute upper respiratory infection, unspecified
J06.9 [45562437]
3.3e-01
6.5e-01
—
—
—
7.4e-01
7.1e-01
cases:5.08%
controls:3.70%
cases:2.67%
controls:1.42%
—
—
—
—
—
—
cases:3.23%
controls:1.57%
cases:12.82%
controls:6.76%
19
138
355
3594
10
53
364
3679
—
—
—
12
58
359
3636
45
238
306
3284
Infiltration anesthesia
WX110 [2001310767]
-3.9e-02
1.0e-01
9.6e-01
—
—
7.1e-01
2.2e-01
cases:8.56%
controls:8.87%
cases:4.01%
controls:3.64%
cases:1.87%
controls:0.72%
—
—
—
—
cases:8.89%
controls:4.60%
cases:21.37%
controls:17.92%
32
331
342
3401
15
136
359
3596
7
27
367
3705
—
—
33
170
338
3524
75
631
276
2891
ibuprofen
R02AX02 [1588667]
1.1e-01
1.8e-01
8.0e-01
—
3.0e-01
4.1e-01
3.9e-01
cases:34.22%
controls:31.81%
cases:17.38%
controls:14.92%
cases:4.01%
controls:1.85%
—
—
cases:2.41%
controls:1.80%
cases:20.49%
controls:14.62%
cases:46.44%
controls:37.02%
128
1187
246
2545
65
557
309
3175
15
69
359
3663
—
9
67
365
3661
76
540
295
3154
163
1304
188
2218
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
1.1e-01
1.8e-01
8.0e-01
—
3.0e-01
4.1e-01
3.9e-01
cases:34.22%
controls:31.81%
cases:17.38%
controls:14.92%
cases:4.01%
controls:1.85%
—
—
cases:2.41%
controls:1.80%
cases:20.49%
controls:14.62%
cases:46.44%
controls:37.02%
128
1187
246
2545
65
557
309
3175
15
69
359
3663
—
9
67
365
3661
76
540
295
3154
163
1304
188
2218
Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
93769-8 [1002102]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
0
8
351
3514
betamethasone
C05AA05 [21601610]
3.3e-02
8.2e-01
—
—
2.1e+00
6.7e-01
-2.6e-01
cases:4.81%
controls:4.66%
cases:3.74%
controls:1.69%
—
—
—
—
cases:1.34%
controls:0.16%
cases:2.96%
controls:1.54%
cases:3.99%
controls:5.11%
18
174
356
3558
14
63
360
3669
—
—
5
6
369
3722
11
57
360
3637
14
180
337
3342
Counselling/guidance promoting independent living
SPAT1222 [2001700323]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
—
—
—
—
—
—
0
21
374
3711
—
—
—
—
—
—
Respiratory infection other
R83 [2002000951]
—
—
—
—
—
—
7.1e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.42%
controls:1.70%
—
—
—
—
—
—
12
60
339
3462
Tacrolimus [Mass/volume] in Blood
11253-2 [3026250]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.17%
—
—
—
—
—
—
0
6
351
3516
No disease
A97 [2002000230]
-1.0e+50
—
—
—
—
—
6.9e-01
cases:0.00%
controls:0.75%
—
—
—
—
—
—
—
—
—
—
cases:2.85%
controls:1.45%
0
28
374
3704
—
—
—
—
—
10
51
341
3471
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
-1.0e+50
—
—
—
1.0e+50
—
1.1e+00
cases:0.00%
controls:0.51%
—
—
—
—
—
—
cases:1.34%
controls:0.00%
—
—
cases:2.28%
controls:0.74%
0
19
374
3713
—
—
—
5
0
369
3728
—
8
26
343
3496
Menopausal and other perimenopausal disorders
N95 [45582429]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.20%
—
—
—
—
—
—
0
7
351
3515
Puncture of maxillary antrum
TDM10 [2001301819]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.43%
—
—
—
—
—
—
0
15
351
3507
ropinirole; oral
N04BC04 [21604476]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
0
5
351
3517
Atherosclerotic heart disease
I25.1 [45596196]
—
—
—
—
—
—
-2.0e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.28%
controls:2.78%
—
—
—
—
—
—
8
98
343
3424
Sprain and strain of finger(s)
S63.6 [45564454]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
0
10
351
3512
Sleep disorder, unspecified
G47.9 [45595948]
-1.0e+50
—
—
—
—
-1.0e+50
-1.0e+50
cases:0.00%
controls:0.16%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.14%
cases:0.00%
controls:0.14%
0
6
374
3726
—
—
—
—
0
5
371
3689
0
5
351
3517
hydroxyzine; oral, parenteral
N05BB01 [21604590]
1.2e+00
1.8e+00
—
—
—
—
9.9e-01
cases:2.67%
controls:0.86%
cases:1.60%
controls:0.27%
—
—
—
—
—
—
—
—
cases:3.13%
controls:1.19%
10
32
364
3700
6
10
368
3722
—
—
—
—
11
42
340
3480
Palpitations/awareness of heart
K04 [2002000547]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.19%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.23%
0
7
374
3725
—
—
—
—
—
0
8
351
3514
Sodium [Moles/volume] in Urine
2955-3 [3003181]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.20%
—
—
—
—
—
—
0
7
351
3515
bisoprolol; oral
C07AB07 [21601689]
-6.9e-01
-5.1e-01
—
—
-3.7e-01
-4.0e-01
-1.4e-01
cases:3.48%
controls:6.73%
cases:3.74%
controls:6.08%
—
—
—
—
cases:1.34%
controls:1.93%
cases:4.04%
controls:5.90%
cases:7.41%
controls:8.46%
13
251
361
3481
14
227
360
3505
—
—
5
72
369
3656
15
218
356
3476
26
298
325
3224
Gas panel - Venous blood
24339-4 [3000991]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
—
0
5
371
3689
—
Transposition of ligament of shoulder, arthroscopic
NBE35 [2001307284]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.17%
—
—
—
—
—
—
0
6
351
3516
Myopia
H52.1 [45533352]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.34%
—
—
—
—
—
—
0
12
351
3510
Skin, Preventive immunization/medic
S44 [2002001008]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
0
8
351
3514
Photocoagulation of retina
CKC12 [2001301394]
—
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
—
—
cases:0.00%
controls:0.27%
—
—
—
—
—
—
cases:0.00%
controls:0.30%
cases:0.00%
controls:1.19%
—
0
10
374
3722
—
—
—
0
11
371
3683
0
42
351
3480
Rehabilitation Hospital
283X00000X [38004285]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.24%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.19%
—
—
0
9
374
3723
—
—
—
—
0
7
371
3687
—
Diabetic maculopathy
H36.01 [2000502321]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
cases:0.00%
controls:0.19%
cases:0.00%
controls:0.13%
—
—
—
—
—
—
cases:0.00%
controls:0.14%
cases:0.00%
controls:0.45%
0
7
374
3725
0
5
374
3727
—
—
—
0
5
371
3689
0
16
351
3506
Patch test
41778007 [4218642]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.16%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
0
6
374
3726
—
—
—
—
—
0
9
351
3513
brompheniramine, combinations
R06AB51 [21603466]
-9.9e-02
—
—
—
—
—
5.4e-01
cases:1.87%
controls:2.06%
—
—
—
—
—
—
—
—
—
—
cases:2.85%
controls:1.68%
7
77
367
3655
—
—
—
—
—
10
59
341
3463

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
338
21
1622.14
307.65
3.4
1.8
31.84
36.90
%
0.76
338
21
293
16
833.89
307.65
3.8
3.0
31.05
36.73
%
0.83
70
11
337
94
344.92
307.65
9.1
4.5
145.21
443.09
mg/l
1.42
327
47
359
435
170.99
307.65
17.3
7.7
0.92
1.01
mmol/l
7.45
359
418
298
314
42.35
296.57
3.1
1.8
—
—
—
0
0
294
304
41.14
295.53
5.5
1.4
—
—
—
0
0
347
482
84.02
293.27
6.3
1.6
—
—
—
0
0
257
311
24.08
226.75
2.7
3.3
29.25
46.68
u/l
0.65
252
262
353
1083
39.51
139.78
17.7
6.9
—
—
—
0
0
73
12
75.30
133.91
3.6
1.7
37.71
25.25
%
2.11
73
12
276
697
12.21
125.12
5.6
3.1
—
0.00
—
0
7
75
22
42.36
121.14
3.4
2.4
14.72
16.55
%
0.33
75
22
370
1661
92.97
112.44
14.2
7.8
11.47
12.55
umol/l
1.10
370
1599
320
1088
14.24
105.34
7.3
3.8
64.60
93.78
e6/l
0.24
167
778
291
923
10.61
100.95
14.2
6.1
—
—
—
0
0
365
1552
51.69
94.07
22.8
7.0
2.85
2.93
%
0.38
365
1480
365
1554
51.58
93.88
22.8
7.0
8.95
8.86
%
0.39
365
1486
364
1547
47.12
93.67
22.9
7.0
0.79
0.70
%
3.25
364
1470
365
1561
51.18
93.22
22.5
6.9
50.54
57.42
%
35.55
365
1513
365
1596
49.26
89.98
22.9
7.0
35.94
27.61
%
50.88
365
1535
334
1340
14.65
88.25
6.0
3.0
6.22
6.07
ph
0.99
89
809
280
941
8.80
88.19
5.4
2.5
—
0.14
—
0
14
83
77
13.56
80.27
1.2
1.1
—
—
—
0
0
52
24
24.99
71.39
5.2
2.4
983.02
712.63
e6/l
0.78
47
19
347
1643
15.89
71.30
6.2
3.1
0.00
0.00
estimate
-0.00
44
332
82
90
11.38
70.50
1.2
1.1
—
—
—
0
0
348
1663
16.18
70.49
6.2
3.2
0.00
0.02
estimate
0.79
45
296
347
1661
15.59
69.89
6.2
3.2
0.00
5.30
estimate
0.50
46
330
87
113
9.72
65.78
1.2
1.3
199.70
243.74
miu/ml
0.34
27
52
57
0
+∞
61.14
1.1
0.0
—
—
—
0
0
217
815
4.95
52.39
4.0
3.0
0.26
0.43
e6/l
0.51
152
587
46
32
16.25
51.94
2.9
1.7
—
—
—
0
0
231
951
4.72
48.44
4.0
3.2
19.82
40.71
e6/l
1.27
168
721
283
1444
4.91
42.46
2.5
1.9
1.46
1.53
mmol/l
0.52
274
1264
56
74
8.72
41.05
2.4
3.8
1.83
2.70
index
0.35
12
47
238
1103
4.17
40.02
5.1
3.7
9.21
9.11
mmol/l
0.10
232
963
163
583
4.18
39.77
1.6
1.7
—
—
—
0
0
143
472
4.28
38.87
3.4
2.9
2.42
1.21
e6/l
0.44
61
216
148
515
4.10
37.14
3.4
2.7
0.92
0.80
e6/l
0.21
66
257
37
47
8.62
27.75
2.1
2.6
45.10
41.18
iu/ml
—
7
5
35
45
8.48
25.96
1.1
1.3
—
—
—
0
0
55
130
4.79
22.21
1.6
1.6
1.22
1.60
g/l
2.09
49
120
127
548
2.99
20.83
3.3
2.6
608.72
569.56
mosm/kgh2o
1.19
120
489
369
3108
12.70
20.60
10.6
4.6
6.01
6.00
mmol/l
0.06
369
2933
136
641
2.76
18.59
3.5
2.7
2.93
5.12
e6/l
0.95
131
588
83
1683
0.35
16.47
5.1
2.9
—
—
—
0
0
28
51
5.85
15.01
4.0
3.5
2.92
4.33
e9/l
3.90
28
51
32
70
4.90
14.04
3.7
3.2
50.53
57.52
%
2.42
32
70
36
91
4.27
13.23
1.2
1.6
152.38
146.17
au/ml
—
8
27
136
733
2.34
13.21
1.6
1.6
18.00
19.42
nmol/l
0.75
129
649
48
155
3.40
12.45
7.2
3.7
—
—
—
0
0
343
2808
3.60
12.05
34.7
17.8
13.34
13.45
%
1.00
343
2785
365
3121
7.36
11.98
10.5
5.8
36.23
39.06
mmol/mol
9.22
365
3001
370
3342
9.03
11.48
11.1
4.9
1.30
1.34
mmol/l
1.55
370
3187
20
35
5.98
11.12
1.2
1.0
—
—
—
0
0
369
3345
7.44
10.59
11.3
5.0
4.47
4.67
mmol/l
5.04
369
3206
370
3364
8.49
10.55
11.5
5.4
2.76
2.82
mmol/l
0.89
370
3214
37
113
3.52
10.43
1.2
1.2
—
—
—
0
0
14
6
24.16
10.31
1.2
2.5
—
—
—
0
0
33
94
3.75
10.30
1.2
1.3
—
—
—
0
0
19
19
10.47
10.13
6.3
3.2
41.55
31.43
mu/l
0.47
19
19
20
28
7.48
8.85
1.2
1.0
—
—
—
0
0
364
3224
5.40
8.72
19.1
14.9
21.70
23.49
mg/l
0.53
304
2634
31
101
3.26
7.90
4.4
3.4
—
—
—
0
0
39
146
2.87
7.85
2.6
2.2
0.00
4.79
estimate
—
9
53
53
239
2.42
7.37
2.3
2.1
0.00
0.05
estimate
—
10
61
58
273
2.33
7.33
6.3
5.5
0.00
0.15
%
2.62
13
87
110
663
1.93
7.28
2.3
2.1
2.47
2.89
mg/l
1.21
101
587
131
838
1.87
7.22
5.5
5.0
—
—
—
0
0
58
275
2.31
7.21
5.9
5.1
0.21
0.61
%
1.32
14
94
57
272
2.29
6.97
6.9
5.9
0.00
0.08
%
—
10
79
146
979
1.80
6.83
3.6
3.7
81.95
62.25
mg/l
0.38
106
681
59
289
2.24
6.78
6.2
5.3
0.36
0.90
%
1.46
14
105
127
864
1.71
5.41
3.3
4.5
7.39
7.40
ph
0.40
84
618
313
3410
0.50
5.29
12.5
12.6
—
—
—
0
0
47
240
2.10
4.86
1.8
3.2
66.81
76.39
e9/l
0.99
26
173
140
1005
1.63
4.73
4.0
4.3
10.93
10.39
mg/mmol
0.06
95
681
23
86
2.78
4.67
1.3
2.4
63.93
107.17
mg/l
0.26
23
70
329
2936
1.98
4.62
35.1
17.6
336.70
335.37
g/l
1.88
329
2927
24
93
2.69
4.57
2.8
2.6
—
—
—
0
0
42
211
2.12
4.53
4.3
2.8
—
—
—
0
0
168
1274
1.58
4.45
2.2
2.6
72.19
71.15
nmol/l
0.16
162
1187
38
185
2.17
4.43
2.2
5.4
74.24
96.47
ng/l
1.21
38
176
23
89
2.69
4.39
1.4
1.1
—
—
—
0
0
55
310
1.91
4.32
13.2
13.7
—
—
—
0
0
56
318
1.89
4.30
3.2
4.0
0.19
1.90
mmol/l
1.82
44
282
10
17
6.01
4.15
1.0
1.1
155.50
163.03
nmol/l
—
10
17
22
86
2.66
4.13
1.3
2.4
52.58
53.08
mg/l
0.01
22
70
43
226
2.02
4.12
4.3
2.7
—
—
—
0
0
68
416
1.78
4.12
1.1
1.3
—
—
—
0
0
162
1237
1.55
4.06
2.0
1.9
98.87
96.94
pmol/l
0.28
107
707
21
81
2.69
4.04
1.2
2.1
1.10
1.21
ratio
—
9
42
43
229
1.99
3.98
4.4
2.6
—
—
—
0
0
43
229
1.99
3.98
4.3
2.7
—
—
—
0
0
56
331
1.81
3.79
3.2
4.1
7.35
7.38
ph
2.49
37
194
7
234
0.29
3.74
1.0
1.1
1.02
0.92
g/l
—
7
234
30
144
2.18
3.64
1.8
2.5
21.63
21.18
s
0.18
30
131
42
229
1.94
3.64
4.4
2.5
—
—
—
0
0
34
172
2.07
3.62
1.8
2.1
—
—
—
0
0
83
555
1.64
3.61
3.3
2.5
—
—
—
0
0
7
229
0.29
3.60
1.0
1.1
1.55
1.44
g/l
—
7
229
68
432
1.70
3.60
1.4
1.6
—
—
—
0
0
49
286
1.82
3.46
1.6
2.3
12.74
10.83
g/l
1.60
44
263
85
582
1.60
3.35
3.1
3.7
36.99
587.70
ng/l
2.41
63
428
10
25
4.08
3.10
1.6
3.7
1218.70
1356.76
mg
—
10
25
70
471
1.60
2.95
1.3
1.3
240.00
392.69
titre
0.92
14
93
25
122
2.12
2.94
1.1
1.1
—
—
—
0
0
33
179
1.92
2.93
1.3
1.2
—
—
—
0
0
92
1231
0.67
2.90
3.0
3.3
22.61
37.36
ng/l
0.98
49
803
58
377
1.64
2.81
2.1
1.7
946.66
1186.14
nmol/l
1.55
53
307
176
1442
1.42
2.79
7.5
9.2
1.20
1.20
mmol/l
0.24
159
1273
41
244
1.76
2.74
1.7
1.8
0.35
0.35
mg/l
0.02
28
126
10
29
3.51
2.71
1.0
1.2
—
—
—
0
0
17
75
2.33
2.55
2.2
1.5
—
—
—
0
0
99
746
1.44
2.44
1.7
1.9
—
—
—
0
0
164
1351
1.38
2.42
10.8
12.4
1.19
1.19
inr
0.05
137
1130
148
1771
0.73
2.32
3.7
4.0
1.85
1.73
ug/l
0.09
140
1645
16
72
2.28
2.31
2.8
4.0
—
—
—
0
0
15
66
2.33
2.27
2.9
4.3
4.73
5.05
kpa
1.53
15
66
15
66
2.33
2.27
2.9
4.3
9.61
9.06
kpa
0.77
15
66
15
66
2.33
2.27
2.9
4.3
1.35
2.71
mmol/l
—
6
45
91
685
1.43
2.25
1.4
1.4
3.30
2.57
g/l
1.11
42
475
11
41
2.73
2.22
2.9
1.7
—
—
—
0
0
6
167
0.35
2.20
2.0
1.6
—
—
—
0
0
8
24
3.38
2.19
2.9
5.3
1.25
0.87
index
—
8
24
238
2637
0.73
2.15
4.8
3.7
63.67
53.85
u/l
0.80
225
2539
8
193
0.40
2.11
1.1
1.6
—
—
—
0
0
37
232
1.66
2.08
1.6
1.5
1.64
1.25
g/l
0.24
32
219
9
31
2.95
2.08
1.1
2.1
—
—
—
0
0
7
20
3.55
2.06
1.0
1.1
585.14
248.48
iu/ml
—
7
20
116
928
1.36
1.99
5.1
3.8
2.36
2.35
mmol/l
0.34
101
863
5
142
0.34
1.92
3.0
3.7
25.80
25.17
mmol/l
—
5
135
8
182
0.43
1.87
3.5
7.6
—
—
—
0
0
11
46
2.43
1.87
1.3
1.5
—
—
—
0
0
32
204
1.62
1.72
1.3
1.2
—
—
—
0
0
45
311
1.51
1.72
5.0
10.7
9.02
8.47
mmol/l
0.22
45
301
63
466
1.42
1.71
2.2
2.3
—
—
—
0
0
52
371
1.47
1.70
1.3
1.3
—
—
—
0
0
10
40
2.54
1.68
3.0
1.6
—
—
—
0
0
7
25
2.83
1.65
1.0
1.6
3.27
4.74
mg/l
—
7
25
11
49
2.28
1.65
1.0
1.1
—
—
—
0
0
11
49
2.28
1.65
1.5
1.5
—
—
—
0
0
36
239
1.56
1.65
1.1
1.4
—
—
—
0
0
16
284
0.54
1.61
1.1
1.1
—
—
—
0
0
11
50
2.24
1.58
1.6
1.6
—
—
—
0
0
6
21
2.89
1.51
1.0
1.1
—
—
—
0
0
94
759
1.32
1.48
1.3
1.3
2.22
1.30
u/ml
—
10
242
24
148
1.66
1.48
1.2
1.5
—
11.83
—
0
7
15
81
1.89
1.42
2.3
1.4
28.50
15.89
e6/l
—
10
56
17
96
1.81
1.41
1.1
1.3
219.38
227.61
u/ml
—
8
60
164
1431
1.26
1.40
2.8
3.0
214.09
158.16
ug/l
0.49
159
1376
117
984
1.27
1.35
2.4
2.5
—
—
—
0
0
73
576
1.33
1.35
2.8
4.3
0.82
0.82
mmol/l
0.07
66
554
25
161
1.59
1.32
1.1
1.1
—
14.20
—
0
5
16
91
1.79
1.31
5.1
4.2
39.44
36.58
umol/l
0.18
16
85
91
745
1.29
1.29
1.9
1.9
3.13
1.18
mg/l
0.52
70
586
6
25
2.42
1.25
1.7
1.2
—
—
—
0
0
74
903
0.78
1.17
2.2
2.8
347.24
359.08
umol/l
0.51
68
834
0
35
0.00
1.15
0.0
3.1
—
33.89
—
0
35
0
35
0.00
1.15
0.0
1.7
—
—
—
0
0
54
418
1.34
1.15
1.8
1.8
—
—
—
0
0
131
1138
1.23
1.12
2.2
2.0
—
—
—
0
0
7
31
2.28
1.11
1.1
1.2
—
—
—
0
0
102
864
1.25
1.10
6.2
3.3
0.00
0.00
estimate
0.50
45
304
5
21
2.40
1.09
1.0
3.0
—
—
—
0
0
5
21
2.40
1.09
1.0
1.6
—
—
—
0
0
5
21
2.40
1.09
1.0
1.7
—
—
—
0
0
11
59
1.89
1.08
1.4
1.3
—
—
—
0
0
112
1291
0.81
1.07
5.9
3.0
0.00
0.00
estimate
-0.00
40
283
7
34
2.08
1.03
1.1
1.2
—
—
—
0
0
5
108
0.46
1.02
2.8
11.3
—
—
—
0
0
9
157
0.56
1.01
1.1
1.1
—
—
—
0
0
7
133
0.52
1.01
2.1
1.2
—
2.63
—
0
7
10
54
1.88
0.97
1.4
1.2
—
—
—
0
0
0
31
0.00
0.97
0.0
1.6
—
—
—
0
0
13
77
1.71
0.96
1.3
1.4
499.83
11641.87
e6/l
—
6
53
0
32
0.00
0.95
0.0
3.0
—
0.99
—
0
23
32
235
1.40
0.95
8.0
3.4
—
—
—
0
0
21
143
1.50
0.92
1.1
1.3
—
—
—
0
0
95
1098
0.82
0.91
2.4
2.6
0.71
0.66
ug/l
0.09
67
558
215
2307
0.84
0.90
3.0
3.8
—
14431.00
—
0
7
337
3261
1.33
0.90
20.6
17.2
3.94
3.99
mmol/l
3.09
331
3206
8
42
1.92
0.89
1.4
1.1
—
—
—
0
0
15
95
1.60
0.88
2.9
4.3
7.42
7.41
ph
0.44
15
95
18
120
1.53
0.87
1.1
1.2
—
—
—
0
0
35
266
1.35
0.86
1.2
1.2
—
—
—
0
0
10
59
1.71
0.76
2.3
1.8
—
—
—
0
0
0
28
0.00
0.76
0.0
1.2
—
—
—
0
0
9
55
1.65
0.74
1.0
1.7
—
—
—
0
0
9
55
1.65
0.74
1.0
1.7
—
—
—
0
0
9
55
1.65
0.74
1.0
1.7
—
—
—
0
0
9
55
1.65
0.74
1.0
1.7
—
—
—
0
0
51
420
1.25
0.72
2.0
3.0
214.01
131.53
ug/g
0.57
39
363
38
470
0.79
0.69
1.4
1.5
—
—
—
0
0
15
212
0.70
0.65
1.9
3.7
136.47
134.58
g/l
0.17
15
207
7
44
1.60
0.65
1.6
2.1
12.29
10.99
mmol/l
—
7
44
334
3253
1.24
0.63
19.3
17.1
139.07
139.69
mmol/l
5.37
329
3203
13
185
0.69
0.59
2.7
3.0
0.53
0.64
%
1.33
13
185
16
115
1.41
0.57
2.3
2.7
22.65
24.62
mmol/l
1.52
16
115
6
37
1.63
0.56
1.2
1.3
—
—
—
0
0
6
38
1.59
0.54
1.0
1.3
—
—
—
0
0
7
47
1.50
0.48
1.1
1.1
—
—
—
0
0
43
366
1.20
0.47
14.7
13.8
-1.06
1.03
mmol/l
2.26
34
315
36
301
1.22
0.47
1.9
2.1
49.81
36.79
nmol/l
1.40
36
296
7
49
1.44
0.46
1.6
2.7
—
—
—
0
0
33
393
0.82
0.45
1.3
1.4
—
—
—
0
0
43
368
1.19
0.45
14.7
13.8
7.41
7.42
ph
0.34
16
200
242
2325
1.12
0.44
3.2
3.7
13.91
14.58
pmol/l
4.56
230
2183
56
494
1.16
0.42
2.7
3.1
2.44
2.43
mmol/l
0.28
42
443
12
161
0.74
0.42
1.6
1.6
255.25
266.15
mu/l
0.13
12
153
0
15
0.00
0.41
0.0
6.6
—
17.96
—
0
15
0
16
0.00
0.41
0.0
6.9
—
10.55
—
0
11
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
1.3
—
26.82
—
0
11
52
588
0.87
0.40
1.4
1.3
36.48
28.93
iu/ml
0.16
12
169
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.0
—
223.08
—
0
12
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
0
19
0.00
0.39
0.0
1.3
—
0.16
—
0
19
8
113
0.70
0.37
2.1
2.1
—
—
—
0
0
43
487
0.87
0.35
1.7
1.5
—
—
—
0
0
12
155
0.77
0.34
1.2
1.5
19.97
18.99
iu/l
—
6
125
53
476
1.13
0.32
13.1
10.0
104.92
104.26
mmol/l
0.46
53
476
7
52
1.35
0.31
3.3
2.5
—
—
—
0
0
10
76
1.32
0.28
2.0
3.0
9.00
8.31
kpa
—
10
76
8
65
1.24
0.27
1.5
1.5
154.60
171.20
pmol/l
—
8
65
23
198
1.17
0.25
1.1
1.2
136.20
111.16
u/ml
—
5
69
135
1412
0.93
0.25
2.8
2.8
—
—
estimate
—
0
0
48
523
0.91
0.23
1.4
1.3
4.26
8.29
u/ml
—
10
217
0
11
0.00
0.21
0.0
1.3
—
71.18
—
0
11
0
11
0.00
0.21
0.0
2.0
—
16.72
—
0
11
0
11
0.00
0.21
0.0
1.3
—
12.11
—
0
11
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
6.9
—
25.18
—
0
13
0
13
0.00
0.21
0.0
1.7
—
3.62
—
0
13
14
117
1.20
0.21
1.2
1.2
—
—
—
0
0
6
50
1.20
0.20
1.2
1.1
—
—
—
0
0
92
967
0.94
0.19
5.4
2.6
0.00
0.01
estimate
0.80
40
264
79
833
0.93
0.18
8.9
5.3
—
—
—
0
0
8
68
1.18
0.16
1.5
1.3
—
—
—
0
0
77
732
1.07
0.16
6.5
3.4
1.02
1.02
kg/l
0.92
57
467
20
224
0.89
0.16
2.0
1.7
6.07
6.05
ph
0.03
14
131
24
223
1.08
0.09
2.5
3.6
4.80
5.17
kpa
2.42
24
217
5
61
0.82
0.08
1.6
4.0
8.32
9.46
pmol/l
—
5
61
55
530
1.04
0.08
1.6
1.7
417.18
46875429.22
pmol/l
0.80
49
480
8
92
0.87
0.07
1.3
1.7
—
—
—
0
0
17
183
0.93
0.06
1.2
1.5
11.69
5.55
u/l
—
9
150
285
2865
0.98
0.04
4.7
4.5
1.86
1.84
mu/l
0.09
277
2707
11
101
1.09
0.04
1.1
1.1
—
—
—
0
0
11
101
1.09
0.04
1.1
1.1
—
—
—
0
0
16
153
1.05
0.01
2.7
3.8
—
—
—
0
0
10
94
1.07
0.01
1.4
1.5
182.02
271.18
ug/g
—
10
53
25
248
1.01
0.00
2.1
2.1
247.68
226.28
pmol/l
0.58
25
236
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
3.0
—
6985.63
—
0
8
0
6
0.00
-0.00
0.0
2.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
46.67
—
0
6
0
5
0.00
-0.00
0.0
2.0
—
85.40
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
69.33
—
0
6
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
47.80
—
0
5
0
6
0.00
-0.00
0.0
1.2
—
6.40
—
0
6
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.8
—
206.60
—
0
5
7
72
0.97
-0.00
1.4
1.3
50.74
25.79
u/l
—
7
64
0
6
0.00
-0.00
0.0
1.2
—
2.22
—
0
6
0
7
0.00
-0.00
0.0
1.3
—
73.29
—
0
7
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
2.20
—
0
5
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
96
960
1.00
-0.00
1.3
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
40.60
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
1.17
—
0
9

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_HIV_NOS and mortality.

Females

No data

Males

Parameter HR [95% CI] p-value
AB1_HIV_NOS 3.161 [2.63, 3.81] < 0.001
Birth year 0.985 [0.98, 0.99] 0.002

During the follow-up period (1.1.1998 — 31.12.2019), 201 out of 1214 males with AB1_HIV_NOS died.

Mortality risk

Mortality risk for people of age

years, who have AB1_HIV_NOS.

N-year risk Females Males
1 No data 0.477%
5 No data 3.193%
10 No data 8.646%
15 No data 14.951%
20 No data 24.987%

Relationships between endpoints

↥

Index endpoint: AB1_HIV_NOS – Unspecified human immunodeficiency virus [HIV] disease

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data